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EDC…………………... .N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride 
EDTA………………………………………………………Ethylenediaminetetraacetic acid 
EthD-1………………………………………………………………Ethidium homodimer-1 
FBS………………………………………………………………………Fetal bovine serum 
FDM…………………………………………………………… Fused deposition modelling 
G………………………………………………………………………………………Gauge 




HA ………………………………………………………………………….Hyaluronic acid 
HEPES……………………………… 4-(2-hydroxyethyl)piperazine-1-ethane-sulfonic acid 
HL………………………………………………………………………………...Lift nozzle 
HMW-HA…………………………………………..High molecular weight hyaluronic acid 
Hn, Ln…………………………………………………………………………Needle length 
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LMW-HA…………………………………………...Low molecular weight hyaluronic acid 
M……………………………………………………………………………………… Molar 












PBS……………………………………………………………….Phosphate buffered saline 
PCL……………………………………………………………………….. Polycaprolactone 
PEA………………………………………………………………………Poly ethyl acrylate 
PEG……………………………………………………………………. Polyethylene glycol 
PGA………………………………………………………………………. Polyglycolic acid 
PLLA………………………………………………………………………... Poly(L-lactide) 
RGD………………………………………………………… Arginine-glycine-aspartic acid 
rpm…………………………………………………………………..Revolutions per minute 
s………………………………………………………………………………………Second 
Sd………………………………………………………………………….Standoff distance 











































Extracellular matrices (ECMs) in soft tissues are highly hydrated structures mainly 
composed of glycoproteins (such as collagen or fibronectin) and glycosaminoglycans (such 
as hyaluronic acid (HA) or keratan sulfate), each one with a tissue-specific composition (1). 
Many of these tissues are unable to regenerate themselves or can only repair minor injuries, 
as is the case of skin (2), heart (3) and cartilage (4).  
Hydrogels are hydrophilic polymeric networks with high water retention capability which 
have been frequently proposed as potential candidates for soft tissues regeneration due to 
their tunable physical, chemical and biological properties, biocompatibility and their ability 
to mimic the native ECMs (5-7). Besides, they promote phenotype maintenance and induce 
re-differentiation of different cells such as cardiomyocytes (8), chondrocytes (9) and 
hepatoblast (10).  
Most hydrogels need to be chemically cross-linked to not dissolve at body temperature. 
Conventional cross-linking methods involving chemical reactions are generally cytotoxic. 
Solvents, initiators or unreacted substances are left behind, often resulting in inflammation 
and cell death (11-13). In order to prevent any harmful effect on cells, they must be therefore 
pre-formed under safe lab conditions, thoroughly washed and sterilised before implantation.  
Cross-linking reactions mediated by enzymes (14-16), also known as enzyme-mediated or 
enzyme-catalysed cross-linking, have been proposed relatively recently as a less problematic 
alternative for hydrogel scaffolding. In these systems, aqueous hydrogel precursor solutions 
are mixed with cellular components and/or desired bioactive agents prior to injection into 
the defect area. Enzymes, included or subsequently added to the precursor solutions, catalyse 
the cross-linking reaction immediately upon injection, generating covalent bonds between 
specific functional groups found within the polymer side chains.  
These mild in situ reactions, which can take place in a matter of seconds or minutes, do not 
produce any cytotoxic effects (17,18) and present several advantages (19-21) over pre-
created hydrogels: adaptation to the shape of the defect, lower risk of implant migration, 
easy and effective cell encapsulation and deliverability, and minimally invasive surgical 
interventions that improve patient compliance and recovery (18,22-27).  
Gelatin (Gel) is a natural polymer derived from the partial denaturation of collagen that has 
attracted attention as a hydrogel scaffold into which cells can be embedded. It has accessible 
functional groups that can react with other molecules and different integrin-binding sites for 
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cell adhesion and differentiation (28). However, its poor mechanical properties limit its 
applications. This lack of mechanical strength can be overcome by preparing blends of 
gelatin with other polymers (29) by enzyme-mediated reactions such as hyaluronic acid 
(HA). HA is well known for its high hydrophilicity, good lubrication, biocompatibility, and 
low cell and protein adhesive properties (30). Gel-HA hydrogels enzymatically cross-linked 
by horseradish peroxidase (HRP) and hydrogen peroxide (H202) through the covalent 
bonding of tyramine (Tyr) have demonstrated their non-cytotoxicity and potential for cell 
adhesion and spreading (33-35). HA concentration in this system can be modified according 
to the required stiffness, water sorption, pore size and gelation time (18, 31, 32), which gives 
rise to potential candidates for several types of soft tissue models, regeneration strategies 
and applications in minimally invasive procedures.  
Traditional approaches based on hydrogel or other soft materials for scaffolding are limited 
in their capacity of producing complex microstructures with accurate biomimetic properties. 
Three-dimensional (3D) bioprinting technologies to the contrary, offer a novel versatility to 
co-deliver cells and biomaterials with precise control over their configurations, spatial 
distributions and pattern exactitude, achieving personalized constructs that mimic the 
functionality of target tissues and organs (22, 36-42). One of the most appealing applications 
of 3D bioprinting nowadays is the development of functional 3D tissue models. Current 2D 
cell cultures, particularly the animal models employed for in vitro drug testing, are shown to 
respond differently to drug candidates compared to humans, and hence their use as models 
of human diseases or medical conditions result ineffective and futile (163).  
However, like any other new and complex technology, the process towards its complete 
implementation still has a long way to go. The determination and understanding of the 
parameters involved in a process of hydrogel printing as well as the effects of their 
combination are paramount for the success of the scaffold and can present a challenge even 
to the most veteran researchers.  
In this work, we propose a viable and reproducible cell encapsulation protocol of Gel-
Tyr/HA-Tyr hydrogels by means of 3D bioprinting for in vitro drug testing and further use 
in regenerative medicine, significantly reducing the worker’s laboratory time and facilitating 
the completion of long laborious tasks in multi-sample hydrogel generation. We also provide 
an extensive and well-documented description of several parameters directly involved in 
every process of printing design and protocol optimisation as well as some of their common 




Life in well developed, ageing, ever-growing populations results indubitably shaped by the 
advances in the medical field, and vice versa.  
The rising prevalence of chronic musculoskeletal conditions, the non-stop global increase in 
prevailing causes of death (43), or the constant improvement in surgical techniques, not only 
have all contributed to the severe problem of organ shortage and scarcity of patient-
compatible donors we face today (44, 45), but also to the driving force behind new tissue 
regenerative science, research, and development to overcome it.  
Before the emergence of tissue engineering, strategies to deal with tissue losses were the 
exclusive domain of the surgery repertoire; options were restricted to the use of rudimentary 
artificial prosthetics, organ transplantation, or the autologous transfer of patients’ tissue. 
Nowadays, the use of autografts, allografts, and xenografts continues to be the leading 
therapy solution for numerous damaged tissues (46-54); unfortunately, it is not exempt from 
shortcomings. It stands to reason that, from a biology perspective, there should be no better 
material to replace a living tissue than one of the same nature, and yet despite organ 
transplantation generally saves lives, prolongs lifespan and increases the quality of life of 
thousands of people every year (55), chances are that abnormal interaction, dislodgment, 
infection, eventual chronic rejection and failure (56-62), to name a few, still occur on a fairly 
regular basis. Ironically, it is all mostly due to the same reason why they are found so 
attractive for replacement, their peculiar subjection to the body´s response. 
Biocompatibility is the primary requirement of an implantable material, unrelatedly to its 
origin. When a biomaterial comes into contact with a biological system, biocompatibility 
assures an appropriate host reaction with no immune, thrombogenic, toxic, or allergic 
inflammatory response. Tissue grafts are formed by a variety of cells contained in an organic 
matrix; glycoproteins, antigens present on the cell surface membrane, can be recognised by 
the human leukocytes and remain strongly immunogenic compared to the ones in the 
extracellular matrix (ECM) (63, 64). Even though some grafts are accepted in their entirety 
by the organism and can incorporate the own patient´s cells, as a general rule, tissues as is 
the case of heart valves, must dispose of all the foreign biological signalling before their 
clinical use, leaving exclusively the remaining acellular matrice but morphologically and 
mechanically similar to the original organ composition. Some chemical and physical 
processes used to suppress immunogenicity may interfere with cellular recolonization, 
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interaction, and remodelling of the cell environment, never integrating into the recipient 
tissue (65, 66).  Nonetheless, albeit all the existing biological, economical, clinical, and 
ethical limitations associated with organ donation and/or their obtention, decellularized 
tissues today are mostly provided from bovine or porcine specimens, being currently and 
successfully used as implants for bone, tendons, ligaments, and heart valves, as well as 
providing less aggressive alternatives to organ transplantation. 
Not surprisingly, the market has reflected an increasing demand for alternative high-
performance biomaterials over the past few decades, where tissue engineering and 
regenerative medicine arenas have so far become a hallmark of state-of-art biomaterial 
research. It is no wonder either that, the global biomaterial market is becoming one of the 
most profitable markets in the coming years, with an estimated value of USD 121.1 billion 
in 2020 and a predicted value of over USD 300 billion by 2027 (67). Areas such as vascular 
therapy, cardiology, spine, trauma, orthopaedics, or wound care among others, raise real, 
unique challenges regarding the development of new assorted and functional replacement 
constructs as well as the procedures of their processing and assembly into implantable 
devices (68).  
Available biomaterials currently on the market include a wide scope of materials of 
synthetic, natural, and hybrid nature (69-72). Metals and alloys, ceramics, polymers and 
composites, offer now the opportunity to select among very unique materials to meet the 
specific requirements of the anatomic location, the functionality of the tissue structure and 
pathobiology, healing process, and medical treatment. Examples of this selection include the 
use of high electroconductivity metals as electrodes in artificial organs, chemically inert 
materials for permanent replacement of lost function, or biodegradable materials as 
temporary constructs where regeneration and healing of lost tissue or function are still 
possible (73,74).  
Concerning the latter, the most frequent strategy associated with tissue engineering is the 
use of natural or synthetic biodegradable matrices embedded with living cells and 
biomolecules of interest (75). Those matrices, in a way similar to decellularized tissues, are 
able to mimic the different biological ECMs due to their wide diversity of mechanical and 
chemical properties and, in turn, they renovate or restore tissue´s functionality, providing an 
improvement in the quality of life of those who receive them. In regenerative medicine and 
tissue engineering, those matrices or constructs are commonly known as scaffolds given 
their similar role to the support structures in the building industry.  
23 
 
Scaffolds can be described as three-dimensional, porous, solid biomaterials designed to 
perform some or all of the following functions: (a) promote cell-material interactions, cell 
adhesion, and extracellular matrix (ECM) deposition; (b) allow sufficient diffusion of gases, 
nutrients, and regulatory factors to permit cell survival, expansion and differentiation; (c) 
possess a degradation rate similar to the regeneration rate of the replaced tissue, and (d) 
cause minimal inflammation or toxicity to the organism (76). 
The criteria for selecting suitable scaffold biomaterials is therefore based on their mechanical 
strength, surface energy and chemistry, porosity and interconnectivity, molecular weight, 
solubility, shape and structure, hydrophilicity, water absorption, degradation and erosion 
mechanism (77). To date, polymer and polymer composites have been widely studied and 
used in several engineering disciplines including biomaterial research, since their optimal 
characteristics tend to be more easily and reproducibly controlled, especially when compared 
to other typical materials (78). 
 
1.1. Polymers for scaffolding 
Polymers are by far the largest and more versatile class of biomaterials regarding their 
variety of physical, biological and mechanical properties. They have been thoroughly studied 
and used for the manufacture of medical devices as well as for tissue-engineering scaffolds 
(79,80) as a result of their chemical tunability, biocompatibility, high porosity with very 
small pore size, high surface-to-volume ratio, and an extensive selection of fabrication 
techniques and final forms. The similarities between the long-chain architectures of 
biological tissues and natural polymers such as proteins or polysaccharides, or synthetic 
polymers, have motivated researchers to successfully attempt to grow skin and cartilage (81), 
bone and cartilage (82), heart valves and arteries (83), nerves (84), and other various soft 
tissues (85).  
They can be categorised based on their origin, structure, properties, and molecular 
arrangement of their repeating units. Depending on their origin, polymeric scaffolds are 
principally classified into synthetic or biologic, degradable or non-degradable (77).  
1.1.1. Natural polymers 
Natural and naturally-derived polymers were the first group of biodegradable biomaterials 
used for clinical applications (86). These materials, some of them after a process of 
derivatization, are effortlessly recognised and accepted by biological systems due to their 
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native bioactive properties and superior cell-material interactions, as well as metabolically 
processed through established pathways in the organism (87). As a result of their similarities 
with the native ECM, natural polymers have been frequently used as skin substitutes where 
some of them are well-known for their hemostatic properties, antimicrobial properties, or 
encouraging reepithelization when seeded with skin cells (88). 
However, naturally-occurred polymers lead sometimes to immunogenic reactions or 
pathogens transmission, becoming difficult to purify and sterilise (89). In other cases, they 
can be very costly and complex if resource availability is limited or present batch-to-batch 
variations in their final properties, transforming them into a challenge to reproduce with 
accuracy. Compared to their synthetic counterparts, natural polymers generally exhibit a 
narrow and scarce range of mechanical properties (87), compromising their use in hard tissue 
applications; current developments in nanocomposite technology offer the chance of 
enhancing this rigidity, mechanical strength and other properties by blending processes and 
composite preparation, combining the properties and the synergetic effects of their 
components (90).   
The most predominant natural polymers used in biomedical applications are protein-based 
(e.g., collagen, gelatin, silk, fibrinogen, elastin, keratin) and polysaccharide-based (e.g., 
cellulose, amylose, dextran, chitin, hyaluronic acid).  
Proteins or peptides, well-known for their controlled natural degradability, are the major 
component in natural ECMs and most probably present the key to a new generation of 
biomaterials. Proteins properties are inherently connected to their composition and chemical 
structure, formed by repeated short amino acid sequences; recent studies show that not only 
will be possible in a near future to tune properties of specific proteins by changing these 
sequences organisation but also to combine appealing qualities of different proteins by 
fusing their complete sequences altogether, giving rise to a new series of proteins with novel 
enhanced properties (91-96).  
Polysaccharides, on the other hand, consist of long-chain carbohydrate molecules composed 
of individual monosaccharide units bound together by glycosidic linkages. Their molecular 
formula is CX (H2O)y where x can be from 200 to 2500 (87). Polysaccharides are often 
isolated and purified from renewable resources (e.g., plants, animals, microorganisms), 
broadly distributed in nature and thus further away from scarcity. Similarly, this peculiar 
group of polymers has structural resemblances, chemical versatilities as well as comparable 
biological functionalities to the organic ECM components, which mitigates the immune 
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response of the organism (97). Polysaccharides are rather heterogeneous molecules, they can 
contain small variations in their repeating units and, as a result, own dissimilar properties to 
molecules from another batch (98). The most exploitable and attractive advantage of these 
polymers relies on their freely available hydroxyl and amine domains along with their 
structures, becoming possible to bind synthetic monomers or other bioactive molecules to 
their structures and hence to alter their physicochemical properties. This possibility offers 
the best features of both worlds, natural and synthetic, opening the door to a new collection 
of natural polymer-based semi-synthetic biomaterials alongside the development of new 
methodologies and modelling tools to predict their optimal properties (97).  
 
1.1.2. Synthetic polymers 
Synthetic polymers, regarding their non-natural derived origin, are free from 
immunogenicity (66) but lack chemical and biological signalling, something that, from a 
cellular perspective, makes them less recognisable and attractive for cell attachment. Many 
synthetic polymers need to be functionalised before their use to acquire specific binding 
domains, responsible for cell attachment and spreading on the biomaterial surface. 
Common functionalisation techniques include mixing, surface coating or surface grafting 
polymerization (66, 99). Notwithstanding, their benefits far outweigh any possible 
drawback: synthetic polymers can be designed, synthesized and tailored in large uniform 
quantities; they possess predictable and reproducible physical and mechanical properties, 
including elastic modulus, tensile strength, degradation rate or degree of porosity; 
compared to natural polymers, their synthesis and processing are generally easier and 
cheaper; and since they do not include any biological material that may be compromised, 
they can also be kept for longer shelf times. Some synthetic polymers examples are 
polyesters (e.g., polyglycolic acid (PGA), poly(L-lactide) (PLLA), polycaprolactone 










Hydrogels are three-dimensional hydrated networks based on the cross-linking of natural or 
synthetic polymers. They can be tuned to obtain favourable physical, chemical and 
biological scaffold properties (5-7) with the intention to emulate their native ECM 
counterparts. Hydrogels scaffolds share biochemical similarities with the highly hydrated 
glycosaminoglycans (GAGs) components of connective tissues, which are very elastic, 
flexible, and possess highly viscous properties (100). 
Given their structure, hydrogels are eligible for perfusing with hydrophilic nutrients and 
growth factors (66). They are highly biocompatible and biodegradable, with the ability to 
encapsulate cells in 3D microenvironments during and after the cross-linking process (100, 
118, 119) without undermining cell´s natural behaviour (8-10), cell-substrate interactions, 
or cell-to-cell interactions (120), making them perfect for bioinks and 3D biofabrication 
techniques. They have been extensively explored so far for many biomedical applications 
including cell culture substrates and scaffolds for tissue regeneration (101-107), cell 
encapsulation and delivery (102, 104, 108-111), drug and protein delivery (112-115), and 
biomedical devices involving microfluidics or responsive materials (115-117).  
Based on the polymers that comprise them, hydrogels can be classified into synthetic or 
natural. Synthetic hydrogels are hydrophobic with strong chemical bonds, resulting in 
materials with low degradation rates and excellent mechanical strength, however, due to 
their poor number of binding domains, cells cannot often attach to them (66). Hydrogels 
based on natural polymers on the contrary are inherently biodegradable and biocompatible, 
but present similar issues to the rest of polymers from biological origin. Although a great 
number of organs exhibit very soft consistencies, no more than a few tissues possess 
mechanical properties akin to natural hydrogels; indeed, the main drawback of hydrogels is 
their inherent weakness, which limits their application in medium-hard tissues. Hydrogels 
lacking mechanical integrity often suffer from the loss of their designed shape, providing 
insufficient mechanical strength in weight-bearing actions such as in bone and joints (78). 
In terms of fabrication and processing, they are also strongly subjected to stresses such as 
compression or sheering (66), breaking apart without difficulty. Various methods have been 
applied to improve the mechanical properties of polymer-based hydrogels, such as chemical 




Hydrogels are cross-linked networks produced by covalent or noncovalent bonds that do not 
dissolve at physiological temperature. The generation of cross-linking bonds can be induced 
by several mechanisms such as physical processes, by applying heat or cold, chemical 
processes by the addition of chemical cross-linkers, photochemical processes by the 
activation of photo-reactive chemical groups, and enzymatic processes by enzyme catalysis. 
Chemical, physical and photochemical cross-linking are well-known strategies that usually 
rely on incompatible external stimuli or cytotoxic reactions, where some initiators or 
unreacted intermediate substances remain after the gelation process. Many of these reactions, 
performed under lab conditions, often produce inflammation and cell death (11-13), 
restricting hydrogel applications cross-linked by these methodologies.  
 
1.2.1. Enzymatically crosslinked Gel-Tyr/HA-Tyr hydrogels 
Recently, increasing interest has been focused on enzymatically cross-linked hydrogels 
(1921), also known as enzyme-mediated or enzyme-catalysed, where covalent cross-links 
are generated by mimicking the biological cross-linking methods of the organism using 
enzymes, always occurring under mild, physiological conditions. The ability of enzymes to 
form cross-linked protein networks has been exploited to alter the appearance and the texture 
of food products, to strengthen protein-based fibres for textile manufacturing, or to develop 
new biomimetic tissue scaffolds. The majority of the enzymes involved in the cross-linking 
can be commonly found in catalysing reactions naturally occurring inside biological 
organisms (242-246). Enzymatic reactions are catalysed by most enzymes at neutral pH and 
moderate temperatures, which facilitates the in situ formation of hydrogels as well as the 
cross-linking of natural polymers that cannot resist harsh chemical conditions. Another 
major advantage relates to the substrate specificity of the enzyme. Enzymes have usually 
evolved to catalyse one reaction, or a particular type of reaction, where the level of 
specificity depends on the function of the particular enzyme. Unwanted side reactions or 
toxicity are, therefore, avoided since reactions do not randomly occur in undesired locations 
of the hydrogel (247). Cell encapsulation and deliverability result uniform, easy and 
effective given the poor requirements of temperature, toxic chemicals or light radiation 
(17,18), presenting a simple mechanism for the generation of cross-linked constructs and 
improving the mechanical strength of peptide/polysaccharide hydrogels in applications 
where material robustness is essential. 
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Minimally invasive procedures are highly advantageous in tissue engineering therapies, 
presenting an innovative alternative for the replacement of tissues. In situ cross-linkable gels 
are based on aqueous precursor solutions with cellular components and/or bioactive agents 
that can be administrated via injection. Injectable scaffolds eliminate the need for 
complicated surgical interventions improving patients’ compliance and recovery (18,22-27) 
at the same time that they overcome the risk of implant migration and infection. Most 
importantly, integration within wounds and tissue defects is permitted by the in situ cross-
linking, being possible to apply during endoscopic or arthroscopic procedures thanks to the 
initial viscosity of the precursor solution before gelation.  
Gelatin (Gel) protein is one of the main integral components of skin, bone, cartilage, and 
connective tissues. It has superior advantages like biocompatibility, biodegradability and the 
absence of harmful byproducts (121-123). It is less immunogenic than collagen, relatively 
cheap, and has great potential for promoting cell attachment, differentiation, and 
proliferation (124,125). Gelatin naturally contains various available integrin-binding 
domains like arginine-glycine-aspartic acid (RGD), domains that are recognised by cells and 
used to attach to the material surface and spread.  
Gelatin hydrogels have been studied for some time, gaining significant attention in arenas 
like drug delivery and regenerative medicine thanks to their solubility in water and various 
organic solvents and therefore their facility for being processed and used along with a wide 
selection of natural and synthetic polymers (126-128). Due to their potential porosity, gelatin 
hydrogels can absorb until 45 times their weight in liquid, capable of being totally reabsorbed 
into the system in 4 to 6 weeks (129).  
Gel is derived from the partial denaturation of collagen. Depending on how hydrolysis is 
catalysed, either under acidic (Type A) or basic (Type B) conditions, gel can be obtained in 
two different forms and present slight variations in some of their properties. One of gel’s 
peculiar properties lies in its isoelectric point. The isoelectric point indicates the pH value at 
which a molecule carries no net electrical charge, a value that in the case of gelatin is altered 
depending on how collagen is extracted. This property allows gelatin to bind with either 
positively or negatively charged molecules, including therapeutic agents or growth factors. 
Based on this, both acidic and basic gelatin molecules with isoelectric points of 5.0 and 9.0 
respectively, can be used in hydrogel form as controlled release devices under physiological 
conditions (130). Type A gelatin presents more carboxylic groups, making it preferable for 
scaffolds over type B (131). Research conducted by Lee et al. (2016) assessed the influence 
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of both types in GelMa properties, finding a higher degree of methacrylation in type B, 
whereas type A presented a higher resolution after extrusion printing (132).  
 
 
Gelatin-based hydrogels have been investigated as potential bioinks for 3D printing, due to 
their easy, flexible and smooth deposition and tunable shape by mechanical means. Gelatin 
physically cross-links below its sol-gel transition temperature (≈ 35°C), where the protein 
chains partially aggregate and attempt to regain their original triple helical structure observed 
in collagen; regions where the helical structure is reformed and stabilized by intramolecular 
bonds act as cross-linking points (133). Above gelatin´s gelation point, these regions are no 
longer stable and gelatin loses its semi-solid state, becoming soluble in water again. Due to 
this dependency effect on temperature, gel´s viscosity becomes inversely proportional to 
temperature, where bioink solutions can be adjusted at the moment of deposition and acquire 
specific thickness levels, according to the requirements of the printing method employed. 
Like other natural polymers, gelatin possesses low mechanical strength, limiting its 
application in some tissues such as in muscle or cartilage. This problem can be overcome by 
the preparation of gelatin blends with other natural or synthetic polymers (134), which 
benefits from gelatin´s natural adhesion and cell signalling properties in exchange for 
increasing the mechanical properties of the whole mixture.  




Hyaluronic acid (HA) is a naturally occurring polysaccharide of alternating N-acetyl-D-
glucosamine and D-glucuronic acid (135). It has been successfully used in scaffolds for 
neural (136), bone (137), cartilage (138), and corneal (139) tissue regeneration applications. 
HA, like gel, is ubiquitously present in human ECMs and other vertebrates, found in 
locations that include synovial fluid, vitreous humour, skin, and other many tissues where 
friction occurs, including joints, tendons, and pericardium (140, 141). HA participates in 
many key processes, including tissue regeneration, wound healing, morphogenesis, matrix 
organisation and cell signalling (142-144). It has many important physiological and 
biological functions; some clinical applications include regulation of inflammation, 
enhanced cell migration, proliferation and differentiation, angiogenesis, osteoconduction, 
healing with less scarring or the treatment of rheumatoid arthritis and knee osteoarthritis 
(145).  
HA is well known for its high hydrophilicity, good lubrication, and biocompatibility, as well 
as for its low cell and protein adhesive properties (30). HA-based hydrogels are only formed 
when chemically cross-linked through the esterification of the carboxyl or hydroxyl groups 
(146). They contain functional binding groups, making them easily coss-linkable with 
peptide polymers. Besides, due to HA high molecular weight, aqueous solutions are highly 
viscous (147), making it a great candidate for bioprinting applications where good 
rheological properties are required. Sufficiently viscous HA solutions have also been 
demonstrated to have shear-thinning properties under certain shear levels (147), decreasing 
momentarily their apparent viscosity when they are extruded. 
In summary, the addition of HA appears to be an excellent option for increasing the 
mechanical properties of Gel hydrogels by different cross-linking methods (148-151), 
especially including the ones enzymatically cross-linked in situ by tyramine (Tyr) conjugates 
(18, 31, 32) using HRP (horseradish peroxidase) and H202  as catalysers.  
HRP enzyme occurs in horseradish roots and catalyses the oxidative coupling of phenols in 
the presence of hydrogen peroxide (H202). Although several functional groups, such as 
aromatic phenols, amines, and phenolic acids can be used for the oxidative coupling, all 
polymers currently used for HRP-catalysed cross-linking utilise phenol as reducing 
substrate, because the cross-linking reaction between phenol groups happens to be much 
faster than other phenol derivatives (248).  
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Promising studies show the great tunability potential of Gel-Tyr/HA-Tyr hydrogels where 
HA concentration can be modified according to the required stiffness, water sorption, pore 
size and gelation time (18, 31, 32), turning out particularly versatile and useful for many 
surgical applications and soft tissue models, including skeletal muscle and chondrogenic 










1.2.2. Hydrogels in biofabrication 
Even though a collection of encapsulated cells and matrices inside a 3D scaffold is 
considerably closer to becoming a functional tissue, three-dimensional platforms have 
proven to be necessary but not always sufficient for the success of fabricated tissues. This is 
mainly due to the low level of biomimetic organisation of the heterocellular environment, as 
well as instability and low repeatability of current 3D scaffold fabrication techniques.  
Results from several 3D studies evince the strong existing cause-effect relationship between 
the increase in dimensionality and a significant positive impact on cell proliferation, 
differentiation, response to mechanical stimuli, and cell survival in cellular 
microenvironments (152-154). Despite this fact, human tissue is anything but a simple and 
homogeneous structure. It consists of several, functional cell types and a vascularized, 
Figure 2. Filling of tissue defects by HRP-catalysed in situ-forming hydrogels using a dual-
syringe for surgical applications (248). The syringe is loaded with a different phenol-rich 
polymer solution in each barrel, either containing HRP alongside cells or H202. When both 
solutions mix and exit from the syringe needle, the ultimate solution results in the in situ 




hierarchical architecture dependent on the tissue type. Proper tissue development, function, 
and adaptation to the environment are all equally triggered by the ECM architecture and the 
populating cells (66). For successful tissue replacement, any fabricated tissue should recreate 
the complexity and heterocellularity of native tissue at different scales (155), as well as lead 
the cells employing chemical and mechanical cues, promoting specific behaviours and 
proliferation rates (66). When the scaffold architecture fails to retain the different cell 
populations, biological response is followed by the formation of thrombi, cysts, or even 
tumours. Similar occurs with mechanical failure, where cells negatively react with 
inflammation or fibrosis that may destroy the scaffold’s integrity. When a scaffold fails to 
provide proper signals for its recognition, cells do not attach to the material surface and their 
health starts to deteriorate as a whole, often ending up in necrosis and/or apoptosis (66). 
Mimicking the biological and functional organization and complexity of native tissues by 
means of biofabrication is now therefore regarded as the next challenge in the complete 
regeneration of tissues in the human body (156).  
Research has repeatedly shown how extracellular matrix deposition and remodelling are not 
only significant steps in functional tissue formation but also decisive in the ultimate result 
of the scaffold. Conventional biofabrication approaches in tissue engineering are typically 
based on scaffold-based or scaffold-guided constructs with a random distribution of cells, 
matrix, and bioactive cues, where their manufacturing does not allow the control of specific 
spatial distribution (157). Vascularisation in 3D models remains an unsolved problem, which 
plays a vital role in tissue growth and survival, and drug delivery. In addition, techniques 
including particulate leaching, freeze-drying, electrospinning, and microengineering, 
typically possess limited reproducibility and versatility in their fabrication procedures, 
generally involving the use of organic solvents, high temperatures or cross-linking agents 
not compatible with living organisms (157).  
The development of new deposition and fabrication technologies allow researchers 
nowadays to design and generate scaffolds with more complex architectures, without either 
compromising the biological components or the clinical outcome of the constructs. 
On that note, hydrogels offer the superior advantage of being processed under more cell-
friendly conditions. Often classified in the biofabrication field as ‘bioinks’, their precursor 
solutions are held together by weak physical interactions that initially enable good deposition 
or printability in the company of biological compounds, followed by chemical or enzyme-
mediated cross-linking stabilisation (156). Hydrogels with high water contents are excellent 
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for the incorporation of cells and bioactive compounds, providing an instructive, aqueous 
3D environment that simulates the native extracellular matrix (156). All these reasons make 
hydrogels particularly attractive for biofabrication.  
1.3. 3D printing in biofabrication 
The term biofabrication commonly refers to the full process of assembly of biomaterials, 
cells, and biochemical agents to produce an organ (158), regardless of the moment of 
introduction of cellular components. The vast compendium of current biofabrication 
techniques provides the organ designer with additional designing options to generate 
singular scaffold configurations. 
The reality is, however, that the promise of three-dimensional organ systems presents to the 
designer today not one but a few intricate puzzles when building even the simplest of tissues. 
The material, with its properties, cellular affinity, and evolution over time; the conditions in 
which the material is handled and assembled, and its integration with the biofabrication 
process, are all interconnected degrees of freedom that require particular setting and 
optimisation to answer a specific medical application. As Burg and Burg (2014) well 
described, the creation of 3D scaffolds that support tissue and organ fabrication ultimately 
relies on the ‘basic’ task of correctly defining “the right process to place the right 
biomaterials with the right characteristics at the right place at the right time” (p.221) (158).   
3D printing, a technique at the cutting edge of the biofabrication field, promises higher shape 
fidelity, lower fabrication times and minimum dependence on the human factor, and even in 
some cases, the simultaneous inclusion of embedded cells throughout the process without 
negatively affecting their survival. 
3D bioprinting is a rapidly expanding field that combines the disciplines of developmental 
biology, stem cells, and computer and materials science (159). 3D bioprinting was first 
demonstrated by Klebe (160) in 1988, using the term “cytoscribing” to refer to the technique 
of positioning cells in a precise way on a 2D surface using a computer-control inkjet printer 
or graphics plotter. The technique started evolving as more research groups joined in, taking 
place approximately twenty years later the first international workshop on bioprinting and 
biopatterning at the University of Manchester (161). In the last decade, interest in the 
discipline dramatically escalated, becoming an emerging technology with many applications 
and providing high reproducibility and precise control over fabricated constructs in an 
automated manner (162). Particularly in the biomedical field, 3D bioprinting refers to several 
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different additive manufacturing (AM) techniques based on different physical principles, 
which can print not only materials but also living cells in a specific location (68). 
Overall, 3D bioprinting aims to construct anatomically accurate tissues, organs and other 
biological systems in vitro to mimic their analogous parts within the human body (155) 
through layer-by-layer material deposition and accordingly to anatomical 3D image analysis 
and computed tomography techniques (163, 164). Other applications include the 
development of 3D tissue models that may eventually replace current 2D cell cultures and 
animal models for in vitro drug testing since animals are shown to respond differently to 
drug candidates compared to humans, and hence result ineffective as models of human 
diseases or medical conditions (163). Altogether, this biofabrication technique offers more 
efficient and less time-consuming processes to create unique, customized products for tissue 
modelling and replacement, becoming one of the greatest highlights in modern medicine 
nowadays.  
However, 3D bioprinting is yet at an early stage and as with any other new, complex system, 
the process towards its complete realization can be rather laborious, iterative and often 
gradual. Whether a bioink is suited or not for 3D bioprinting is mainly defined by the 
material´s rheological properties and the cross-linking method. We also find several system 
properties that influence hydrogel printability and cell viability, including gelation, nozzle 
gauge, shear stress, network properties, and fabrication time (157), all deeply interconnected 
as it will be later described.  
One of the most important components of a 3D bioprinting system is the bioink. Bioinks are 
a mixture of cells, biomaterials and bioactive molecules which compose the substrate of the 
final scaffold during the printing process (163, 100). The four principal types of bioink 
materials are hydrogels, microcarriers, cell aggregates, and decellularized matrix 
components (165, 166). Bioinks are generally required to be biocompatible, biodegradable, 
and should not have any toxic effect on the body, including their waste and intermediates 
compounds. Also, they should enable rapid cell growth and proliferation to start the 
regeneration process. There is a wide-ranging selection of materials that can be used for 
scaffolds; however, due to the cell and material heterogeneity found in the different tissue 
types, the use of several bioinks will be sometimes needed, which have to be optimised for 
precise control over cellular and matrix deposition (68, 165).  
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Bioinks most importantly, compared to conventional fabrication techniques, need to 
preserve and assure cell viability of the embedded cells during the printing process, while 






















The bioprinter itself also plays a pivotal role in the fabrication process. Since tissues and 
organs are highly complex, bioprinter should be able to print the different cell types in the 
company of the biomaterials at a time (165) to assure cellular components reach the centre 
of the scaffold, a task that not all the techniques are capable of. The printed structure should 
Figure 3. Concept map of parameters and relations critical to 3D bioprinting technologies. 
The hydrogel (polymer type(s), concentration, molecular weight and chemical composition 
and cross-linking approach) directly determines the viscosity, gelation mechanism and 
speed, and mechanical properties of the final scaffold. This, in combination with processing 
parameters, such as nozzle gauge and fabrication time influence the main outcomes: printing 




be of a minimum resolution which is dependent on the accuracy of the system, the printing 
method, and the material properties. Other requirements include: sufficient build speed to 
retain the scaffold shape and structural integrity, material and printing versatility, full 
automation capability and user-friendliness, affordability, and ease of sterilization 
techniques to avoid possible infections in surgery or cell studies (167).  
 
1.4 3D bioprinting technologies 
Most of the fabrication approaches reported in literature possess a common limitation and is 
their poor working versatility in cases where the required operational parameters (e.g., 
rheology, pressure, temperature, voltage) are relatively different from the ones established 
by their own working mechanism (168). In other words, each biofabrication technique is 
applicable only in a particular range of the material properties (e.g., viscosity, surface 
tension, cell concentrations, melting point, solvent evaporation), restricting the choice of 
materials.  
1.4.1 Fused deposition modelling (FDM) 
Several additive manufacturing (AM) technologies, which could be potentially used in 
bioprinting applications, work with conditions that often exceed the physiological range, 
becoming incapable of working with cellular components. These techniques lack the 
flexibility to mimic cell distributions in native tissues, especially when strategies for the 
regeneration of multiple tissue interfaces or organs are desirable (168); however, they have 
shown different degrees of success in 3D fabricated scaffolds by adding posterior steps of 
indirect AM to the process. 
The most popular technique in AM is fused deposition modelling (FDM), also known as 3D 
fibre deposition (3DF) or bioextrusion. FDM is based on the hot-extrusion and deposition of 
thermoplastic materials, like synthetic polymers, which are generally provided in filaments 
or pellets shape (168). 
These filaments are melted and deposited layer-by-layer by a heated nozzle on a build 
platform, on which a 3D structure is eventually built. In some cases, a second printhead is 
used to deposit temporary supporting material, or scaffolds can be generated by the 
simultaneous work of multiple printheads. FDM possess the ability to print objects with 
excellent mechanical properties and high porosity. Besides, geometry is precisely controlled 
by horizontal and vertical movement (x,y,z) of the printheads or the platform, depending on 
37 
 
the system. It benefits from low-cost materials, fast fabrication speed, and is easy to operate. 
In terms of bio-applications, FDM shows limitations of material selection compared to other 
conventional methods, where only a few thermoplastic materials are biocompatible enough 
for its use in scaffolds. Moreover, high temperatures employed with these molten polymers 
limit the direct incorporation of biological factors or high water contents, causing natural 














Nonetheless, other techniques based on extrusion and droplet-based (168), allow the direct 
incorporation of cells into a biomaterial carrier or bioink during the process of AM. 
 
1.4.2 Extrusion-based bioprinting 
Another extrusion-based technique is bioplotting, also called extrusion bioprinting (not to 
be confused with bioextrusion, although their names may differ in each classification system 
found in literature). Extrusion bioprinting is the most affordable and common used technique 
in 3D bioprinting (165). Numerous types of tissue have already been studied, including 
neuronal tissue (169, 170), heart valves (171, 172) and cartilage (173, 174). Bioink 
dispensing, in a way similar to bioextrusion, is performed by the application of mechanical 
Figure 4. Diagram of FDM process  (159) 
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or pneumatic pressure at the back of the dispenser (175), allowing the extrusion through a 
micro nozzle of a wide range of materials (176). It fabricates 3D constructs by stacking 2D 
layers (176) of very different materials, from highly viscous hydrogels (≤ 6 x 107 mPa s) 
(163,  177,  178) to cell pellets (169), tissue spheroids (179,180), and tissue strands (181).  
 
Despite having a relatively low resolution (>100 µm) (68) and limited fabrication speed with 
complex shapes, extrusion bioprinting has a few important advantages like the 
implementation of high cell concentration bioinks with excellent cell survival (above 90%), 
scalable production and the ability to print natural polymers and synthetic polymers with 











Published results demonstrated its tremendous versatility in multi-material printing. Ozbolat 
et al. (2014) succeded in the creation of an extrusion ‘Multi-arm’ system capable of 
processing the dispensing of different cell types and materials at the same time, reducing the 
fabrication time and enabling fabrication of more complex structures (182). Other promising 
projects as the one investigated by Liu et al. (2017), alternatively developed a system capable 
of printing simultaneously with a multiple-channel single-printhead. Each channel was 
connected to its own bioink reservoir and computer-aid, devised to open the different valve 
mechanisms only at a required moment of the printing (183). Working with this technique 
 
Figure 5. Extrusion-based bioprinting. (A) Pneumatic via pressurized air, (B) piston-driven 
mechanical or pneumatic extrusion, and (C) screw-driven extrusion (160). 
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requires a minimum material viscosity to assure structure stability. Hydrogels with poor 
viscous properties although being printable, generally need the use of other structural 
bioinks, fugitive materials or plotting baths to prevent deformation of the construct after 
extrusion. Cell sedimentation and pressure influence are also enhanced, making difficult it 
to calibrate specific flow rates and homogeneous cell distributions.     
1.4.3 Droplet-based bioprinting (DBB) 
Droplet-based technologies are simple and agile techniques that deposit picoscale or 
nanoscale droplets on top of a substrate without any contact with the platform surface (176). 
They are highly versatile and able to print at high speed and high resolution, but mostly all 
working modes are only suitable for materials with low viscosities (163, 165), on the 
contrary to extrusion-based systems.  
Due to the general low viscosity requirement (< 30 mPa·s) (184) and to avoid nozzle 
clogging, cell densities in these types of bioinks are generally lower than in other techniques 
(1-3 x 106 cells/mL) (68, 185). Printed constructs have poor mechanical and structural 
integrity (163), and there is a restriction of size in the constructs due to possible cross-
contamination of the bioinks in simultaneous printing. Besides, the uniformity of the droplets 
and the control of vascularisation and porosity of the final constructs need to be improved 




Based on the Rayleigh-Plateau instability principle (163), the bioink solution is ejected 
through a nozzle exit when pressure is applied, breaking up into individual droplets. 
Undesirable droplets are deflected by an electric field to a gutter, where the unused ink is 
recycled for many applications in other disciplines, somehow, for most applications in 
biomaterial science, especially the ones working with encapsulated cells, recycling after 
exposure to the environment is absolutely unviable due to the risk of contamination of the 
process and the bioink (186). 
• Drop-on-demand (DOD) inkjet 
Preferred over continuous-inkjet, DOD systems only generate droplets when desired and 
thus are more economical (163). Rather than an applied pressure, droplets in this inkjet type 
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are formed by breaking the fluid´s surface tension at the nozzle tip. Surface tension is broken 
by the propagation of a pressure pulse caused by different physical principles where if the 
pulse exceeds the pressure threshold at the nozzle, a drop is ejected. However, in the absence 
of pressure application, the liquid is held in place only by the surface tension. Consequently, 
this group of techniques only work with very low viscosity fluids. Although it has some 
advantages over other printing methods such as its low cost and high resolution (20-100 um) 
(176), due to the small size of the printed droplets, time of processing is considerably 
increased and final constructs lack mechanical strength (176). Based on their physical 
principle, we find:  
• Thermal-induced system. The actuator is locally heated when applying a voltage pulse, 
creating a vapour bubble that rapidly expands and bursts (68, 163).  
• Piezoelectric-induced system. When the voltage pulse is detected, the piezoelectric 
actuator suffers a physical deformation transferred to the fluid chamber, producing a 
pressure wave (68,  163).  
• Electrostatic forces. Volume in the fluid chamber is increased by the action of an 
electrode and a pressure plate. The pressure plate deflects from its original position after 
a pulse is applied (68, 163).  
• Electrohydrodynamic jet. This inkjet technique follows a slightly different approach 
compared to the rest of the DOD systems. In the resting phase, bioink is pushed to the 
orifice exit by back pressure, forming a rounded meniscus at the tip due to the surface 
tension. When a high voltage (0.5-20 kV) is applied between the nozzle and the surface 
substrate, the potential difference causes the mobile ions of the material to accumulate 
near the meniscus surface, overcoming the surface tension. Changing the applied 
voltage, bioink properties and flow rate, the system allows different jetting modes, from 


















This approach consists of the generation of droplets under pneumatic pressure (176), 
controlling the opening and closing of the nozzle gate by means of an electromagnetic 
microvalve. The microvalve contains a solenoid coil and a ferromagnetic plunger that blocks 
the exit in the absence of electricity. When the electromagnetic field is generated, the valve 
coil at top of the printhead attracts the plunger upwards, unblocking the orifice. If the 
pneumatic pressure is large enough, bioink is ejected (68, 176). Depending on the applied 
pressure and the valve opening times, this technique allows different modes, continuous or 
dripping dispensing. Longer valve-opening times and pressures facilitate the deposition of 
more viscous bioinks (1-70 mPa·s) (187, 188) compared to other droplet-based systems 
(inkjet-based: 3-30 mPa·s) (1184), but excessive pressure can generate undesired satellite 
droplets during deposition (187). Despite the micro-valve system can print even more high 
 
Figure 6. Inkjet bioprinting. (A1) Continous-inkjet, (A2) Thermal DOD inkjet, (A3) 




viscous bioinks (up to 200 mPa), slow filament elongation is found in viscous properties 
above 70 mPa s (187, 189), which produces unstable flow rates. 
As a rule, volume in droplets generated by micro-valve printers tends to be larger in 
comparison with other droplet-based techniques, regardless of the nozzle geometry, which 
substantially reduces resolution (176). However, printed cells with this approach are found 
to be highly viable, retaining their function, genotype and phenotype, and being able to 












Acoustic-droplet ejection bioprinting 
Unlike the rest of inkjet systems, bioinks in this approach are well kept in an open reservoir 
held in place by the surface tension at small converged exit conduct, generating droplets on-
demand employing acoustic waves. When voltage is applied, the acoustic actuators placed 
upon the exit create circular waves towards the acoustic focal point, exceeding the surface 
tension and ejecting the bioink (68). An important disadvantage of this technique is the loss 
of control over droplet ejection due to the possible disturbances when either the printhead or 
substrate are in movement. Another disadvantage includes the incapacity to print with 
 
Figure 7. Micro-vale bioprinting (163). 
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middle-high viscosity materials at high cell density ratios such as the case of some 











1.4.4 Hybrid bioprinting 
Many research groups have started to develop what are called “hybrid” bioprinting systems 
(193-196), where grafts are constructed by alternate deposition of stiff thermoplastic 
polymers and cell-laden hydrogels. This approach allows the use of multiple hydrogels (and 
thus multiple cell types and bioactive factors), and since hydrogels are supported by the 
thermoplastic material, a broader range of hydrogel formulations can be exploited compared 
to bioprinting of hydrogels alone. Hydrogel requirements for viscosity and gelation speed 





Figure 9. Schematic overview of a 
hybrid bioprinting process. Once the 
thermoplastic material is extruded 
and cooled, hydrogel bioprinting 
can be performed layer-by-layer by 
different approaches, generating a 
hybrid 3D structure (193). 
 




1.5. Operational parameters in bioprinting 
Adaptation of extrusion-based and droplet-based systems for very different scaffold 
applications instigate researchers to understand the fundamentals and interaction of the 
different working parameters, such as pressure, nozzle geometry, flow rate, or standoff 
distance (94, 198-200), which ultimately define the process and the scaffold success. 
However, factors influencing bioprinting are numerous and interrelated, and therefore they 
won´t be all mentioned in this introduction.  
 
1.5.1. Parameters inside the nozzle tip 
Flow rate and applied pressure 
Flow rate (Q) is expressed as function a of several variables, including applied pressure 
(Papplied), material viscosity (η), nozzle geometry (Ø, L), and surface tension (σ) (95).  
Fluid motion in a dispensing barrel is ideally controlled by a pressure balance between 
internal and external forces. Applied pressure (Papplied) and the weight of the ink inside the 
extruder (mg) are counterbalanced by the frictional resistance of the material viscosity (Pη) 
and wall-plunger parts (Pfr), as well as the atmospheric pressure (Patm), which pushes the 
fluid upwards through the nozzle orifice due to the existing negative pressure inside the 
Figure 10. Another example of layer-by-layer multi-material 3D bioprinting process, where 
scaffolds can be fabricated using supporting materials such as PCL and sacrificial materials 
in company of cell-laden hydrogels with poor shape integrity (197). 
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barrel. When applied pressure exceeds the pressure delta (∆P) at the nozzle tip, a minimal 
flow rate is obtained. Therefore, more viscous fluids extruded through smaller nozzle 





Nozzle geometry is normally divided into two popular types, cylindrical and tapered nozzles. 
Results show that under similar working conditions, tapered nozzles always trigger higher 
pressure gradients, and therefore higher flow rates, compared to cylindrical nozzles 
(201,202). Tapered nozzles typically have larger diameters at the entrance, and smaller ones 
at the tip bottom; a characteristic that provides a favourable pressure gradient, dictated by 
the cone-half angle (θc) and tip diameter (Dt) (202). n situations where the extrusion pressure 
is limited, a tapered nozzle will be the best option for achieving higher flow rates, especially 
with an increase in viscosity or/and a decrease in nozzle diameter (95). 
Shear stress 
Shear stress (τ) is of special interest in bioprinting since it is believed to be the main cause 
of cell damage and loss during printing (203, 204, 205). When a fluid is in motion, shear 
stress is developed due to its contained particles moving relative to one another. If we 
consider fluid motion inside a pipe, which has a similar geometric profile to any printing 
dispenser, fluid velocity will be zero at the surface wall, increasing towards the centre of the 
conduct and being maximum at the centre of the lumen. Shear forces will then occur between 
Figure 11. Illustration of flow dependence on cartridge volume and applied pressure. 
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adjacent layers of the fluid, which relatively move at a different speed, achieving the highest 
value at the edge of the wall. Another term considered of interest and closely related to shear 
stress is the shear rate (ϒ), which is defined as a measure of the rate of relative motion 
between adjacent layers, often expressed as a velocity gradient.  
The level of shear stress is directly dependent on different parameters, such as nozzle 
geometry, printing pressure, and viscosity of the bioink (206, 207). Although blunt 
cylindrical nozzles are conventionally used to print with higher resolution, cells appear to be 
less affected by shear in tapered nozzle designs, generating an approximately 10-fold 
decrease in cell viability post-printing compared to cylindrical nozzles of identical gauge 
(68, 208). Changing the nozzle diameter will also affect cell printability, where the same 
number of cells in narrow versus large nozzle aperture will be differently affected by 
mechanical stressors by other cells and the contact with the nozzle walls (209). Medium 
nozzles sizes (250-800 µm) ensure optimal cell distribution and printing fidelity, 
consequently assuring high cell survival rates during hydrogel flow (209). 
Excessive levels of printing-induced shear stress have shown to have not only an immediate 
impact on cell viability but in the long run also an alteration of cellular behaviour in the cells 
that survived the printing process. For the tested cell types, L929 mouse fibroblast and 
hMSC, Blaeser et al. found that the stress threshold was exceeded when reached 5 kPa (203). 
Figure 12. Schematic illustration of the velocity (u) and shear stress (τ) distribution on cells 
in at the nozzle during a dispensing process (203). 
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Therefore, these phenomena become crucial where, in an attempt to improve the final 
printing resolution, hydrogels of high viscosity and small nozzle geometries are applied.  
In extrusion-based printing, polymer bioinks rely on their viscoelastic characteristics, where 
shear-thinning and self-healing properties are paramount (175). A characteristic shear-
thinning property is important for the extrusion process of bioinks which require high 
viscous formulations since it protects the embedded cells against mechanical stressors during 
flow. In rheology, the viscosity of a polymer is always larger than that of the corresponding 
monomer and increases hastily with higher molecular weight. This is due to entanglement 
and intramolecular forces between the randomly oriented polymer chains (210). Polymer 
solutions including hydrogels, as well as dispersions and melts, are in most cases non-
Newtonian liquids.  
To put it in a nutshell, non-Newtonian fluids possess an apparent viscosity (η) directly 
influenced by the application of different levels of shear rate. Shear-thinning behaviour, 
probably the simplest and most frequent rheological effect (211), occurs in polymers with a 
sufficiently high molecular weight, whose polymer chains begin to disentangle and to align 














Figure 13. Shear-thinning and self-healing effects during polymer solution dispensing.  
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This degree of disentanglement depends on the applied shear rate, wherein theory at 
appropriately high shear regimes polymers should be completely unravelled and aligned, 
therefore behaving like Newtonian liquids, whereas for very low shear rates, polymer chains 
movement should not impede or modify shear flow due to the minimum extrusion speed, 
reaching the called zero shear rate viscosity (η0) (210).  
Apart from shear-thinning, bioink should then be able to self-heal quickly after removal of 
shear to keep structural and mechanical integrity. For this reason, the bioink should harden 
immediately after printing in a cytocompatible manner (175).  
Cellular density  
Cellular density plays a crucial role in the development and fabrication of specific constructs 
due to its direct influence on both cell fate and the physical properties of printed hydrogels. 
According to the tissue of interest, cell density can affect multiple outcomes post-printing. 
Printing low-density bioinks (< 1x106 cells mL-1), although relatively unaffected by shear 
forces, can result in poor tissue integration and ingrowth construct due to poor cell-cell 
interaction and proliferation (209). In contrast, when cell numbers are too high (> 5x106 cells 
mL-1), they can lead to undesired cell over-accumulation in the print head as well as in the 
scaffold, limiting available space to spread and proliferate. Overpopulated cell-laden 
hydrogels can also suffer from pronounced cell hypoxia, cell saturation and disruptive cell-
to-cell interaction (209).  
From gravity’s perspective, higher cell densities in poorly viscous solutions may lead to 
additional sedimentation effects, increasing the chances of clogging events at the nozzle exit 








Figure 14. Cell sedimentation process in poor viscous solutions. 
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Despite this, high cell concentrations have been shown to increase both the overall bioink 
viscosity and its shear-thinning effect, due to the friction exerted by the bioink flow at the 
cell surface (203, 212). An increase in cell density also reduces the surface tension of the 
bioink, improving jet stability (satellite droplets) during droplet formation in droplet-based 
systems (212). However, evidence of a reduction in stiffness of finished cell-laden hydrogels 
has been recently reported with an increase of cell density (213,214), possibly resulting in 


















Last but not least important, to avoid the use of high-pressure levels and consequently suffer 
from high levels of shear stress, fluid viscosity sometimes can be decreased when decreasing 
or increasing the printing temperature (T). Printing temperature can also be altered 
sometimes to prevent cell sedimentation, by increasing fluid viscosity in fluids of low 
viscosity. Somehow, depending on the cell type and the fabrication time, extreme changes 
Figure 15. Cell seeding density influence on 3D cell-laden hydrogel’s polymer strands and 
extrusion through large-size (>800 µm), medium-size (250-800 µm) and small-size (<250 
µm) nozzles. Above, extruded filaments can retain a number of cells (pink) proportional to 
the cell seeding density. Polymeric chains (blue) concentration and distribution directly 
influence cell proliferation capability. Below, maintaining constant the number of cells 
loaded in a printing syringe but changing the nozzle aperture will affect cell printability and 
viability of the final construct (209). 
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in fluid temperature can decrease cell survival during and after printing. Zhao et al assessed 
the differences in cell viability at different temperatures and holding times in 5% gelatin 1% 
alginate hydrogels after printing, showing a significant decline of cell survival rate with the 
increase of holding times at any holding temperature as well as when decreasing holding 
temperature at any holding time (96).  
In summary, the ink flow rate through the nozzle is: (a) inversely proportional to the 
viscosity (η), (b) directly proportional to the applied pressure (Papplied), (c) inversely 
proportional to the pipe length (L), and (d) directly proportional to the nozzle diameter (D) 
(95).  
In the same way, shear stress (τ) during the printing process will generally be: (a) inversely 
proportional to cell viability, (b) directly proportional to the printing resolution, viscosity (η) 
and applied pressure (Papplied), (c) directly proportional to the pipe length (L), (c) inversely 
proportional to the nozzle diameter (D). 
 
1.5.2. Parameters out of the nozzle tip 
Capillary rise effect 
Capillary rise effect refers to the upward rise of dispensed bioink around the nozzle tip (95), 
normally driven by two possible causes. Pneumatic dispensing systems suffer from a time 
lag between the end of pressure application and the end of material flow, producing a build-
up at the nozzle tip during printhead movement from point to point. Second, the capillary 
rise is closely related to the degree of affinity between material and the nozzle surface (215), 
in other words, driven by the ink wettability, tending to increase in hydrophilic nozzle 
surfaces (216), and low viscosity inks. It is reasonable to think that hydrophobic substrates 
will also increase the capillary rise. The material build-up at the nozzle tip can impede 
smooth dispense and reduce the printing resolution.  
Evaporation rate 
Another important parameter is the evaporative effect of the bioink. Significant solvent loss 
can alter ink rheology, and flow rates by causing ink solidification at the tip of the nozzle 
(217-19). Under isothermal conditions, the rate of evaporation is intensified by the ambient 
condition as the degree of humidity and the boiling temperature of the solvent. In cases where 
a bioink has a high capillary rase, chances are it is due to the low viscosity of the material, 
and evaporation rates and material build-up may end in partial clogging of the nozzle. This 
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sometimes can be avoided by increasing flow velocity or by decreasing the standoff distance. 
On the other hand, in cases where the bioink viscosity is somewhat dependent on the printing 
temperature, material build-ups and partial clogging may be more regular. It is also important 
to maintain a uniform printing temperature around the nozzle, as well as prevent stops during 
printing if possible. 
Standoff distance 
The space between the nozzle and the substrate is commonly known in 3D printing as the 
standoff distance (h, Sd, etc.,), which has been seen to have an important influence on deposit 
precision, resolution, and accuracy among the different bioprinting approaches.  
Construct resolution in droplet-based systems results from the level of accuracy obtained in 
the droplet deposition, which is closely related to the important characteristic of droplet 
integrity. When droplet integrity is lost, depending on the droplet size, viscosity, density, 
and surface tension of the bioink selected (68, 163), the droplet may tend to splash or spread, 
either by disintegrating into secondary droplets (splashing), or expanding its surface area 
(spreading) through undesired areas, causing several distortions in the construct final shape 
or in the worst-case scenario, causing structural failure (68, 163).  
The minimum standoff distance in noncontact fabrication methods, like droplet-based 
systems, is described as the distance in which a stretched liquid dispensed from the nozzle 
merges into a single droplet with possible satellite droplets (220). The droplet is formed from 
a single ejected liquid column that rapidly generates a leading drop followed by an elongated 
tail or ligament, that when it eventually breaks can lead to the formation of smaller satellite 
droplets (186). Normally, these drops reach and merge with the leading drop before impact 
on the substrate, making their presence irrelevant. In case they are still present at impact, 
they lead to noncircular impact footprints of the drop, degrading the quality of the printing 
result. To facilitate drop merging in flight, standoff distance in DOD systems is typically 
established approximately in 2-3 mm (186). At a longer standoff distance, droplets trajectory 
may be deviated by undesired airflow from the printing environment. In order to ensure 
stable single drops, it is also customary to set the standoff distance at a minimum.  
Analogously, standoff distance has been demonstrated to have a certain influence on 
extrusion-based flow rates. It has been observed that if other printing parameters are held 
constant, decreasing the standoff distance to less than half the nozzle diameter, resistance to 
flow tends to increase due to the generation of back pressure (221-223). At a high standoff 
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distance (h > π*D) (222,224) otherwise, the bioink filament can become unstable, breaking 
up into discrete droplets due to the Plateau-Rayleigh instability (163). In general, research 
states a standoff distance of similar size as the nozzle diameter in use to achieve a stable and 
continuous filament (222, 225-227). 
In conclusion and to avoid conceptual errors, waste of time and resources, and reiterated 
post-calibration processes, design and validation of efficient bioprinting protocols need to 
be fundamentally based on the biomaterials mechanical properties, rheology, and cell 
affinity; the appropriate implementation of functional bioinks; and the printing 
characteristics, selecting from the beginning the most suitable method for the particular 





















2.  Aims and Objectives  
Regarding all the positive results so far obtained with the group of gelatin-hyaluronic acid 
(Gel-HA) hydrogels enzymatically cross-linked by tyramine (Tyr) conjugates, this master 
project aims is to develop a simple, viable and reproducible 3D bioprinting protocol that 
provides an easier, faster and more automated cell encapsulation and complete hydrogel 
gelation for future drug screening and testing assays, compared to the already established 
manual protocol.  
To do so, this dissertation addresses the following objectives: 
• Literature review, study and selection of the different bioprinting approaches 
available in the workspace, for the set of Gel-Tyr/HA-Tyr.  
• Learning and preparation of the tyramine conjugates (Gel-Tyr) and (HA-Tyr) and  
their blending compositions. Establish a manual gelation protocol for Gel-Tyr/HA-
Tyr hydrogels with and without embedded cells, to use as controls.  
• Assessment of the dispensing mechanism of the hydrogel precursor solutions and 
cross-linking solution in the bioprinting system. Acquisition of the necessary 
technical know-how in the selected bioprinting systems. Detection of the diverse 
working parameters that intervene in the printing process and design of a prior 
calibration protocol that ensures good reproducibility, and limited waste of material 
resources.  
• Development of the bioprinting protocol. Evaluation of its cytocompatibility via the 
analysis of cell cultures assays. Implementation and adjustment of the culture multi-
well plate in the protocol.  
 
Likewise, this project also aspires to pave the way for colleague researchers in a first 
decision-making process concerning the application of fundamentals in bioprinting, where 
bioprinting physics and parameters, hydrogel/bioink properties, or even the selection of the 
correct technology, are necessary to avoid conceptual errors, waste of time and resources, 
and reiterated post-calibration procedures.  
If the reader bears in mind questions such as the following ones:   
Which technique of the ones available would be more suitable for my type of material?  
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Would technique ‘X’ be able to print this material without compromising mechanical 
integrity and cell viability? Would technique ‘Y’ be able to print this material in a 
reproducible way?  
Would parameter ‘Z’ compromise my cell viability during printing? Given yes or no, in 
which interval?  
If technique ‘X’ or ‘Y’ appeared to be suitable for hydrogel printing, to which degree its 
implementation would be worthwhile?  






















3.  Materials and Methods  
3.1. Materials 
3.1.1. Hydrogel synthesis 
• Gel from porcine skin (gel strength 300, Type A), Sigma Aldrich (USA) 
• HA sodium salt from Streptococcus equi, Sigma Aldrich (USA) 
• Tyramine hydrochloride (98%), Sigma Aldrich (USA) 
• N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC), Iris Biotech 
GmbH (Germany) 
• N-Hydroxysuccinimide (NHS, 98%), Sigma Aldrich (USA) 
• 2-(N-Morpholino)ethanesulfonic acid (MES, >99%), Sigma Aldrich (USA) 
• Dialysis tubing (3500 and 12400 MWCO), Sigma Aldrich (USA) 
3.1.2. Hydrogel formation 
• Dulbecco’s phosphate buffered saline (DPBS), Sigma Aldrich (USA) 
• 4-(2-hydroxyethyl)piperazine-1-ethane-sulfonic acid (HEPES), Sigma Aldrich (USA) 
• Potassium dihydrogen phosphate (extra pure), Scharlab (Spain) 
• Sodium chloride (synthesis grade), Scharlab (Spain) 
• Potassium chloride (synthesis grade), Sigma Aldrich (USA) 
• Peroxidase from horseradish Type VI (HRP), Sigma Aldrich (USA) 
• Hydrogen peroxide solution (30% w/w in H2O, with stabilizer), Sigma Aldrich (USA) 
Calcium Free Krebs Ringer Buffer (CF-KRB) solution was prepared with 115 x 10-3 M 
sodium chloride, 5 x 10-3 M potassium chloride, 1 x 10-3 M potassium dihydrogen phosphate, 










Figure 16. Tyramine graft chemical reaction in presence of Gel molecules. EDC and NHS 
are used as catalysers and activators of the reaction (32).  
Table 1. Molar ratios used for tyramine graft reaction in gelatin. 
3.2. Synthesis of Gel-Tyr 
Gel-Tyr synthesis was carried out based on the protocol by Sakai et al. (228) with some 
modifications. The molar ratios used to obtain Gel-Tyr are: 
 
 
When the tyramine graft reaction is carried out, a reaction is produced between the activated 
carboxyl groups of Gel and the free amine groups of tyramine, generating a 2° amine group 











For Gel, 20 mg/mL of gelatine and 50 x 10-3 M MES was dissolved in 20mL of mQ water 
under stirrer at 60°C for 30 min. Then 0.111g of hydrochloride of tyramine was added and 
kept in agitation at room temperature for 20 min.  Then pH was adjusted to 6 and 7 mg of 
NHS was added afterwards till complete dissolution for 30 min. 0.122 g of EDC was finally 
added to the solution and stirred at 37°C for 24h.  Unreacted reagents were removed from 
the solution by means of dialysis against deionized water for 48h (using a dialysis tube of 
12400 MWCO). To preserve the material integrity, Gel-Tyr was lyophilized in a LyoQuest 
(Telstar Life Science Solutions, Japan) at -80°C and sealed in Falcon tubes for any further 
use. 
 
Tyr:COOH EDC:COOH EDC:TYR NHS:EDC 
2:1 2:1 1:1 1:10 
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Figure 17. Tyramine graft chemical reaction in presence of HA chains. EDC and NHS are 
used as catalysers and activators of the reaction (32).  
Table 2. Molar ratios used for tyramine graft reaction in hyaluronic acid. 
3.3. Synthesis of HA-Tyr 
For the HA tyramine grafting, first, HA of low molecular weight (LMW-HA) (around 320 
000 Da) needed to be obtained from acid degradation of the commercial high molecular 
weight HA (HMW-HA) (229). The selection of LMW-HA was determined by the 
impossibility of filtering HA solutions of high molecular weight for their sterilisation and 
later use in culture assays, even when employed at low densities. To do so, a solution of 500 
mL was prepared at 0.1% (w/v) of HA of high molecular weight, reducing its pH to 0.5 with 
the addition of HCl and keeping in agitation for 24h at 37°C. Subsequently, pH was adjusted 
to 7 with NaOH and dialysed against distilled water for 3 days (using a dialysis tube of 3500 
MWCO) to purify the solution. Finally, low molecular weight HA was lyophilized at -80°C 








As in Gel, tyramine grafting in HA chains aims the obtention of molecules with phenol 
moieties capable of reticulating in the presence of HRP and H202 to form injectable 
hydrogels. The chemical reaction follows the same path as with gelatin, generation of amine 
groups as a result of the reaction between carboxyl groups of hyaluronic acid and free amino 
groups of tyramine.   
The synthesis of HA-Tyr was performed following the protocol described by Darr and 
Calabro (230), where the employed molar ratios were:   
Tyr:COOH EDC:COOH EDC:TYR NHS:EDC 





Figure 18. Hydrogel formation of Gel/HA conjugate hydrogels in the presence of HRP 
and H2O2 as catalysers (234). 
 
To obtain HA-Tyr, we prepared a solution of 20 mL at 150 x 10-3 M NaCl in mQ water, 
added 0.276 M MES and 75 x 10-3 M NaOH under stirrer until complete dissolution. Then, 
pH was adjusted to 5.75 and 0.1 g of low molecular weight HA was added to the solution 
and kept in agitation at 500 rpm for 2 hours at room temperature. Once LMW-HA was 
dissolved, 86.5 mg hydrochloride of tyramine was included and stirred for 20 min at room 
temperature. The pH was again adjusted to 5.75 and 47.77 mg EDC and 2.8 mg NHS were 
added to the solution, which was afterwards under stirrer at 37°C for 24h. For the next 2 
days, the solution was dialysed against deionized water at 150 x 10-3 M NaCl for 24h and 
against distilled water for another 24h (using a dialysis tube of 3500 MWCO). To preserve 
the material integrity, HA-Tyr was finally lyophilized at -80°C and sealed in Falcon tubes 
for further use. 
 
3.4. Gel/HA hydrogel formation 
Gel-Tyr/HA-Tyr conjugates hydrogels reticulate through enzymatic oxidative reactions of 
the phenol moieties in the polymer’s side chain, catalysed by HRP (horseradish peroxidase) 
and consuming H2O2 as co-substrate. The oxidative coupling of phenol moieties occurs via 
carbon-carbon bond at the ortho positions or via carbon-oxygen bond between the carbon at 
the ortho position and the phenoxy oxygen position, where the gelation time will be 
dependent on the concentration of both catalysts (231) (HRP and H2O2), the proportion 
Gel/HA (232), the degree of substitution of carboxyl groups obtained, and the concentration 





First, 2 % w/v Gel-Tyr and 2 % w/v HA-Tyr solutions were prepared in CF-KRB, keeping 
HA tyramine conjugate at 4°C overnight and Gel-Tyr at 37°C for 30 min before use. Once 
they were fully dissolved, solutions with different proportions of Gel/HA were obtained 
59 
 
(100/0, 70/30, 50/50, 30/70, 0/100). Finally, 50 µL hydrogels were prepared by mixing 80 
vol% of the Gel/HA mixtures with 10 vol% of 12.5 U mL-1 HRP (1.25 U mL -1 in the final 
volume) and 10 vol% of 20 x 10-3 M H2O2 (2 x 10
-3 M in the final volume).  
To check whether the droplets were completely gelified or not, samples were removed 
carefully from the parafilm with the help of a spatula.  
 
3.5. Degree of substitution of the modified Gel-Tyr and HA-Tyr 
The degree of substitution of tyramine may be explained in this case as the percentage of 
phenol moieties found in the polymer’s side chains, replacing the activated carboxyl groups 
(COOH) after the tyramine graft chemical reaction. In Gel-Tyr and HA-Tyr hydrogels, the 
degree of substitution is considerably constant, providing a useful parameter for both 
grafting verification and reproducibility evaluation among different batches.  
To determine the degree of substitution of the tyramine phenolic groups in Gel and HA, 
solutions of 0.1% (w/w) were prepared for each material, measuring their absorbances with 
a double beam UV spectrophotometer (CECIL CE9200 UV/VIS, Buck Scientific, Norwalk, 
CT, USA) at 275 nm and using as reference a calibration curve of known tyramine 
concentration solutions. At this wavelength, absorbance values for pure Gel and HA were 0 
due to the negative presence of tyramine phenolic groups. 
 
3.6. Gelation time 
To ensure the cross-linking process was completely achieved, 50 µL hydrogels of each 
Gel/HA mixture (100/0, 70/30, 50/50, 30/70, 0/100) were prepared on a parafilm surface and 
cross-linked. Gelation time was taken as the time when the hydrogels could be detached as 
a unit from the surface. 
 





To assess the influence of both catalysts, HRP and H2O2, over the gelation process, gelation 
time was also obtained from the cross-linked droplets under different concentrations of both 
catalysts, HRP (1.25 U/mL, 10 U/mL, 20 U/mL) and H2O2 (3 mM, 4 mM, 5 mM). 
 
3.7. Cell cultures for Gel/HA hydrogels  
Murine C2C12 myoblasts were expanded in Dulbecco’s Modified Eagle Medium (DMEM, 
+ 4.5 g/L + L-glutamine, Gibco) with 1% penicillin/streptomycin (P/S, Gibco) and 20% fetal 
bovine serum (FBS, Gibco) at 37°C and 5% CO2. Cells were thawed at least two days before 
carrying out any assay, changing the medium the following day and always seeded under 
their 10th passage. For each seeding, the medium was removed from flasks (T75-T175) after 
expansion (always under 70% confluence), then washed with DPBS—before adding 
trypsin/EDTA (Sigma-Aldrich) to the culture. Flasks were incubated then for 3 minutes at 
37°C and trypsin was neutralised with (DMEM+ 1% P/S + 20% FBS). Cells were finally 
counted using a Neubauer chamber. For cell culture assays, concentrations of 4x106 cells/mL 
to 8x106 cells/mL were used depending on the culture type (viability – differentiation), being 
the final volume of the hydrogels of 50 µL. 
3.7.1. Hydrogel formation for cell culture experiments 
2% w/v Gel-Tyr and HA-Tyr solutions were prepared by dissolving the lyophilized powder 
in sterile CF-KRB buffer, leaving HA-Tyr solution overnight at 4°C and Gel-Tyr at 37°C 
for 30 min before use. Once the solutions were completely dissolved, they were filtered 
through a 0.22 m syringe filter and distributed among the different compositions in the 
following ratios of Gel/HA (100/0, 70/30, 50/50, 30/70, 100/0). 12.5 U mL-1 HRP solution 
was then added to the prepared solutions at a volume ratio of 10/80 (HRP solution/ (Gel/HA) 
solution) and cells were centrifuged (1000 rpm, 5 minutes) and resuspended in media before 
being added to each HRP + Gel/HA mixture. After every step, solutions were kept in a warm 
bath to assure constant temperature.  
At last, 45 µL of each composition were crosslinked with 5 µL of 20 x 10-3 M H202 on a 
parafilm surface and deposited on each well of the cell culture plate. Finally, medium 
(DMEM + 1% P/S + 20% FBS) was added to each well and incubated at 37°C. 3 replicates 
were always used per each composition, taking 5 pictures per replicate, both positive controls 
cultured with ethanol (cytotoxic) and negative controls on glass were also included. 
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Figure 20. Schematic workflow of manual cell encapsulation and hydrogel formation for 






3.7.2. 3D printing of Gel/HA hydrogels 
Hydrogel precursor solutions used for bioprinting calibration and culture assays were 
obtained following the same protocol of hydrogel formation and cell encapsulation in control 
samples.  
The bioprinter used for this project was a Biosafety 3DDiscovery™ Evolution system from 
the company REGENHU (Villaz-St-Pierre, Switzerland) with two different modalities: 
extrusion-based and droplet-based (micro-valve) printing. UV sterilization and droplet 
calibration were always performed before any cell printing assay to assure volume accuracy 
in the cell-laden mixture and the cross-linking solution. Once the desired droplet volumes 
were established, bioink 2% (w/v) Gel/HA in the company of HRP enzyme and cells (4 – 8 
x 106 cells/mL) were added into a sterilized commercial syringe (3 mL) with a chamfered 
25 G cylindrical tip (Nordson EFD, United States) with the controlled holding temperature 
of 37°C-39°C. 
The required number of samples (25-50 µL, n=3 per composition) were printed on demand 
onto the substrate (parafilm or non-treated multi-well plate) with a flowing rate of 10 – 20 
µL·s-1  and pressure of 5 - 25 kPa for droplet formation, 5 – 10 µL·s-1  and 4 – 8 kPa for 
cross-linking injection and a valve opening time of 25 – 80 ms at 10 – 16 kPa for cross-
linking ejection. Non-treated surfaces were selected to assure correct droplet shapes given 
the high wettability properties of the bioink solutions.   
Once samples were cross-linked on parafilm, they were translated to a cell culture multi-
well plate and left in the incubator at 37°C until complete gelation (≈ 20 min). Samples 
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printed directly on the well plate were excluded from this step. Finally, cell media was added 
to each well and incubated at 37°C and  5% CO2 using growth media (GM) (DMEM + 1% 
P/S + 20% FBS) for viability and cell adhesion assays or differentiation media (DM) 
(DMEM + 1% P/S + 1% ITS-X) for the required period of time (3h-7d). 
 
3.7.3. Cell viability assay (LIVE/DEAD) 
To determine cell viability and cytotoxicity of the cross-linking process of the Gel/HA 
hydrogels, a Live/Dead cell viability/cytotoxicity kit assay (Invitrogen) was used. The 
Live/Dead assay provides a simultaneous determination of the living and dead cells of a 
sample through a two-colour fluorescence detection system (Calcein-AM, EthD-1). The 
polyanionic dye calcein is a cell-permeant dye that becomes fluorescent by entering in 
contact with live-cell esterase inside viable cells, whereas EthD-1 enters cells with damaged 
membranes, like the ones found in dead or dying cells, and binds to nucleic acids [50]. 
C2C12 cells were harvested and seeded at 4 x 106 cells/mL, within a 24-well plate, in 
(DMEM+ 1% P/S + 20% FBS). Cell viability was analysed at 3 h, 1 d and 4 d after seeding 
in hydrogels with different H2O2 concentrations. The medium was removed from the plate 
wells and hydrogels were washed with DPBS-- twice. Samples were then incubated with 
Live/Dead solution (1:4 calcein/ethidium) in DPBS-- at 37°C for 20 min, washed again in 
DPBS-- and observed in an EVOS microscope. 3 replicates were used per each composition, 
taking 5 pictures per replicate, both positive controls cultured with ethanol (cytotoxic) and 
negative controls on glass were also included. 
Images were processed with the ImageJ 1.58j8 software, where cell viability was calculated 
as the fraction of live cells among the total number of cells. The total number of cells was 
used as a cell density parameter for 3h time point, whereas for 4d  time points, cell count 
was used as a non-spread morphology parameter.  
 
3.7.4. Cell adhesion assay (Phalloidin/DAPI) 
To analyse the interaction between cells and substrates, cells were immunostained to localize 
nuclei and actin cytoskeleton. This assay was helpful to study the differences in cell 
morphology caused by the different gelation methodologies.  
C2C12 cells were harvested and seeded at 4 x 106 cells/mL again, within a 24-well plate, in 
(DMEM+ 1% P/S + 20% FBS). Cell morphology was analysed at 7d in different 
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compositions and with different H2O2 concentrations. Hydrogels were washed twice with 
PBS after media removing, fixed with 4 % formaldehyde for 30 min and washed again twice. 
Blocking buffer (BB) and washing buffer (WB) were prepared in PBS/1%BSA/0.02% 
Tween 20, and PBS/0.5% Tween 20 respectively. Cells were then permeabilized with 0.1% 
Triton X-100 in PBS for 20 min, rinse and block with BB for 1 hour. Samples were 
subsequently incubated with phalloidin (1:200) (Alexa Fluor-488), which stains the actin 
filaments, in BB for 2 hours), and washed at least 5 times with WB. For nuclei staining, 
samples were incubated with NucBlue™ for 20 min and washed at least 2 times in WB and 
one last time in PBS before image acquisition with an inverted Zeiss Axio Observer Z1 
fluorescence microscope. Images were again processed with the ImageJ 1.58j8 software. 
Each washing step during the entire protocol was carried out for 5 minutes in gentle agitation. 
ImageJ 1.58j8 software was used to analyse the immunostained pictures, where cell density 
was calculated as the total number of cells counted per image and then normalized by 
surface. Cell growth factor was obtained as the ratio between the final cell number and the 
original cell number.  
 
3.7.5. Myogenic differentiation assay  
C2C12 cells were cultured at a seeding density of 8 x 106 cells/mL, within a 24-well plate 
for 7 days at 37°C. Cells were cultured under differentiation conditions (DMEM + 1% P/S 
+ 1% Insulin-Transferring-Selenium-X (ITS-X, Gibco)) once the cells were properly 
attached to the surface. 
After the culture, cells were fixed, permeabilized and blocked following the same protocol 
as the adhesion assay. Samples were then stained for sarcomeric myosin with mouse primary 
antibody (1:250) (MF-20, Developmental Studies Hydridoma Bank), which stains the 
sarcomeric myotubes, in BB at room temperature for 2 hours; washed several times with 
WB and then secondary conjugated antibody (1:200) (Cy3 a-mouse) was incubated in BB 
with phalloidin (1:200) at room temperature for another 2 hours. Samples were then washed 
at least 5 times and one last time in PBS before image acquisition. Each washing step during 






Figure 21. Biosafety 3DDiscovery™ Evolution bioprinting system. 
3.8. Design and calibration of the bioprinting system 
Bioprinting in three dimensions (x, y, z) is permitted by a mobile block of printheads and a 
build platform. During the printing process, 2D dispensing is performed side-to-side (x) by 
the printhead over the build platform, where the latter is responsible for the system´s back-
to-front (y) movement. Once a layer is finished, the printhead´s top-to-bottom or vertical (z) 
motion allows layer-by-layer displacement, generating the designed 3D object.  
 
The bioprinter used for this project was a Biosafety 3DDiscovery™ Evolution system from 
the company REGENHU (Villaz-St-Pierre, Switzerland). Pressure settings can be manually 
adjusted for each printhead at any moment of the deposition while being visually displayed 
on both right and left panels inside the cabinet. Platform and cartridge heaters are also 
available during the printing process in case of working with temperatures higher than room 
temperature. Besides, the build platform offered the possibility to work not only with 
traditional printing beds such as coverslips or petri dishes but also with multi-well culture 
plates, which facilitates sample handling.  
Our system counted with 3 different printing modalities: a piston-driven pneumatic extruder, 
a microvalve system also driven by a pneumatic piston, and a fused deposition modelling 
system. Due to the early stage of this research and the system´s incompatibility with hydrogel 
bioinks, FDM usage was discarded from the bioprinting process. The printing protocols for 
calibration and hydrogel printing were designed with the Software Suite BioCADTM  
(REGENHU, Switzerland) included in the system, which is based on commonly known 
CAD design tools. Hydrogel and cross-linker solutions were prepared in a similar way to the 
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Figure 22. Printhead modalities in the 3D printing system: pneumatic extrusion, fused 
deposition modelling, and a DOD micro-valve. 
manual protocol and were later introduced into Optimum 3cc Syringe Barrels or Cartridges 


















3.8.1. Design of the bioprinting protocol 
The printing protocol design was based on the limitations of the two left printing modalities 
and the Gel/HA bioink solutions. This project aimed to design a viable bioprinting protocol 
for the automated dispensing and generation of enzymatically cross-linked Gel/HA 
hydrogels in multi-well plates for their further assessment in drug screening and delivery. 
Initially, Gel/HA precursor solutions enzymatically reticulate in contact with HRP and H202, 
where the latter results cytotoxic when concentrations are high enough. Likewise, the cross-
linking process once started occurs within minutes, rapidly increasing the overall viscosity 
of the bioink and directly affecting flow rate, the physical integrity of the construct and shear 
stress sensed by the embedded cells. 
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Figure 23. Conceptual design of the bioprinting protocol: (a) Protocol calibration and 
testing in a hydrophobic substrate and (b) final protocol printing in culture multi-well 
plates. 
Therefore, in a similar way to the manual hydrogel formation, it is important to separate the 





On the other hand, 2% Gel/HA solutions are poorly viscous, acquiring water-like 
consistency at physiological temperature (< 10 mPa s). Very low viscosities benefit from 
droplet-based technologies such as the micro-valve (1-70 mPa s) (187,188), where sample 
volumes can easily reach the nanoscale with excellent reproducibility and accuracy; 
however, cell sedimentation is generally the main concern in long printing times, leading to 
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clogging issues at relatively high cell densities (> 3 x 106 cells/mL) (185). In situations where 
higher cell concentrations are used, as is the case of this project (4-8 x 106 cells/mL), micro-
valve bioprinting is not considered the best alternative for droplet formation. Extrusion 
bioprinting offers no limitation in cell density and bioink viscosity, although it is strongly 
recommended for materials with middle-high viscous properties given the problems of 
spreading, time lags and lack of consistency attributable to constructs with low viscosity. 
For all these reasons, droplet formation was decided to be performed using extrusion 
whereas cross-linking process could be implemented in both modalities. Apart from this, the 
protocol´s design was divided into two stages: calibration, where samples would be 
dispensed in a hydrophobic surface similar to the bottom of the well, introduced into a 
culture plate and analysed; and final bioprinting, where samples would be dispensed from 
the beginning in each well.  
This protocol presents some main advantages: first, it provides the researcher with some 
versatility depending on the 3D printer´s available modalities, number of printheads and 
project´s budget; second, it establishes a useful starting point for the improvement of either 
materials with similar properties or slightly different ones; and on top of that, it facilitates 
their possible use in multi-material bioprinting in the long run.  
 
3.8.2. Calibration of the bioprinting protocol 
Once the bioprinting protocol was decided, operational parameters in both modalities were 
considered and adjusted to assure the printing process did not present any harmful effects to 
the cells survival, was easily reproducible and accurate in solution dispensing.  
The printed droplet volumes can be directly or indirectly set by the modification of the 
available operational parameters of the 3D printing system in question. In this case, the 
required droplet volumes were mainly obtained by the adjustment of the printing pressure 
and the time of application, the nozzle gauge and geometry, printing distance to the surface 


























Figure 24. Illustration of the operational parameters of both modalities, pneumatic 
extrusion and micro-valve bioprinting, and bioink characteristics. Operational parameters 
of the system include the pneumatic pressure applied (PApplied), cartridge temperature (T), 
the volume of solution (Vs) inside the cartridge, standoff distance (Sd) and nozzle 
geometry such as inner diameter (D), length (L) or type. Modification of these parameters 
is responsible for changes in viscosity, flow rate and shear stress. Printing time is 
described by a different parameter in each modality, where tapplied in extrusion is defined 
as the time in which pneumatic pressure is applied, and topen  represents the time in which 
the valve gate is unblocked by the plunger during pressure application. Modification of 
bioink composition also affects its physical properties and cell viability.  
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Nozzle selection and flow rate 
Flow rate during printing was analysed in three different types of 25 G (D = 250 µm) nozzle 
tips: general-purpose, chamfered, and tapered (Nordson EFD, United States). General-
purpose tips are made of polished passivated stainless steel for a wide range of fluids and 
applications, where tips ending in chamfered shaped allow microdot applications of low 
viscous fluids. On the other hand, tapered tips are normally made of plastic and are 
recommended for smooth flows in applications for medium-to high-viscosity fluids.  
To assess the influence on flow rate produced by the applied pressure (Papplied) and the 
cartridge volume (Vs), both parameters were set at different values, Papplied (4 kPa, 5 kPa, 6 
kPa) and Vsol  (1 mL, 2 mL, 3 mL). To discard possible viscosity interferences at the nozzle 
tip, buffer solution was used for the dispensing (η≈ 1 mPa·s-1) at room temperature (Troom = 
17°C - 20°C). 
Individual droplets (Vd ≤ 10 µL, n ≥ 4) were dispensed on a parafilm substrate at different 
time shots (ts ≤ 0.7s) at the same standoff distance (h=0.3 mm) where flow rate (Q) in each 
case was calculated as the droplet final volume divided by its dispensing time. Droplet 
volume was approximately obtained from each sample by means of a 20 µL micropipette 
(Eppendorf). 
Flow gradient was calculated as the slope of the regression line for each data set of Papplied 
and Vsol as a descriptor of flow rate variability.  
Density and viscosity approximation  
Density of the different precursor solutions was calculated based on Gel and HA density of 
dry polymer, ρgel = 1,44 g·cm
-3 (235) and ρHA = 1,229 g·cm
-3 (236) and buffer solution (ρ ≈ 
1 g·cm-3). Ideal behaviour was assumed to estimate the density of the mixtures (70/30, 50/50, 
30/70), using the mass fraction (X) and density of pure Gel and HA hydrogel solutions at x 
w/v (%) (ρ(x%)), as well as the volume fraction of the mixtures. 
                                                                                                                            
                                                                                                                                     (Eq. 1) 
  
                                                                                (Eq. 2) 
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Relative viscosity values were roughly approximate at 37°C for further calculation by 
following Hagen-Poiseuille´s flow equation (102):  
(Eq. 3) 
 
where Q is the dispensing flow rate (m3/s), ∆p is the pressure drop between the beginning 
and the end of the nozzle tip (Pa), R is the inner radius of the nozzle tip (m), η is the dynamic 
viscosity of the bioink (kg/(m·s)), and L is the length of the nozzle tip. The apparent viscosity 
of the buffer solution (mQ water in its vast majority) was taken as a reference point (η ≈ 1) 
for direct comparison.  
Calculation of Reynolds number, shear stress and pressure drops intervals 
Shear stress inside the barrel and nozzle tip was previously calculated to assure no damage 
to the cell suspension during the printing process. The nature of flow can be verified through 
the calculation of Reynold´s number (Re), which determines flow conditions:                                                                                                      
                             
                                                                       (Eq. 4) 
where ρ is the density of the bioink (kg/m3), Q is the dispensing flow rate (m3/s), D is the 
diameter of either the syringe barrel or the nozzle tip (m), and η is the dynamic viscosity of 
the bioink (kg/(m·s)). In laminar regimes (Re < 2100), the velocity profile is stable and 
parabolic across the diameter, finding the maximum shear stress at the barrel wall. In these 
cases, the wall shear stress, τwall (N/m
2 = Pa), for each flow rate can be easily calculated 
according to Hagen-Poiseuille´s equation (Eq. 3):                                                                               
(Eq. 5) 
  
where Q is the dispensing flow rate (m3/s), η is the dynamic viscosity of the bioink 
(kg/(m·s)), and R is the inner radius of either the syringe barrel or the nozzle tip (m).  
Shear stress effect on cells will be dependent on the cell type, the level of force exerted on 
cells and the time of application. Theoretical values for pressure drop inside the nozzle tip 
were also represented using (Eq. 3) to show tip diameter, bioink viscosity and flow rate 
influence. Printing pressures must be always above the pressure drop value for the generation 




Evaporation rate approximation 
The evaporation rate of different droplet sizes of buffer solution was experimentally obtained 
using a Theta optical tensiometer (Biolin Scientific, Stockholm, Sweden). Images were taken 
every 100 seconds for 15 mins at room temperature. Droplet height and contact radius were 
obtained with help of the ImageJ 1.58j8 software for each image, where droplet volume was 
approximately adjusted and calculated afterwards using the formula of the spherical cap:                  





2)                                 (Eq. 6) 
where Vc is the droplet volume (µL), hd is the droplet height (mm), and rc is the droplet 
contact radius. The evaporation rate was then expressed as the volume loss per unit of time 
for different initial droplet volumes. 
Cell sedimentation rate 
Cells suspended in poorly viscous solutions (ρ < ρcell = 1.1 g/mL) (237) tend to sediment due 
to gravity´s action. The sedimentation rate of cells was calculated using the following 
formula: 
                                                                  (Eq. 7) 
 
where 𝑣𝑠 is the sedimentation rate (m/s), d is the cell diameter (m), ρc and ρ𝑣  are the density 
of the cell and the solution (kg/m3) respectively,  g is the gravitational acceleration (m/s
2), 
and η is the dynamic viscosity of the bioink (kg/(m·s)). 
Standoff distance and physical printing design in CAD environment 
Standoff distance calibration plays an important role in both steps of the bioprinting protocol, 
(1) droplet formation and (2) cross-linking injection or ejection, and hence it is necessary to 
adjust it before printing.  
For droplet formation and cross-linking, standoff distance calibration was based on the 
droplet height and reference values shown in literature for microextrusion and droplet-based 
modalities. Droplet height for the different Gel-Tyr droplet volumes (1 µL - 50 µL) was 
obtained via image from the optical tensiometer, where the height of each sample was 
calculated using ImageJ 1.58j8 software.  
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Standoff distance intervals obtained in this part of the study were afterwards used for the 
adjustment of the physical operational parameters involved in the different stages of the 
bioprinting protocol. 
 
3.9. Statistical analysis 
Data were reported as mean-standard deviation. Pre-processing and normalization of data 
with the D’Agostino-Pearson omnibus test were performed to assure normal distribution. 
Analysis of statistical differences was conducted using student T-test and One-way ANOVA 
(Graphpad Prism 6.0) for two-sample comparison or different groups respectively, using a 
Tukey HSD post hoc test to compare the different groups for normal distributions or a 




















4.  Results and discussion 
4.1 Degree of substitution 
The degree of substitution can be explained in this case as the number of phenol moieties 
found in the polymer’s side chains per 100 COOH molecules. This parameter was quantified 
by means of a spectrophotometer (238), determining the concentration of tyramine graft in 
Gel and HA chains at 275 nm. The degree of substitution obtained for Gel was 4.16x10-4 
mol Tyr/mg whereas HA obtained a value of 2.57x10-4 mol Tyr/mg. These values, divided 
by the COOH mol/mg in each polymer, resulted in an average percentage of substitution of 
























Gelatin-Tyr 0.1032 4.13E-04 34.43
Gelatin-Tyr 0.1033 4.14E-04 34.46









HA-Tyr 0.0623 2.49E-04 6.30
HA-Tyr 0.0663 2.65E-04 6.71 6.5 ± 0.29 
HRP / H2O2 
1.25 u/mL  / 2 mM 10 u/mL 20 u/mL 3 mM 4 mM 5 mM
6.4 ± 1.1 4.3 ± 0.5 4 ± 0.4 4.2 ± 0.4 3.4 ± 0.6 3.1 ± 0.7
6.9 ± 0.5 3.2 ± 0.6 3 ± 0.4 4.4 ± 0.4 4.2 ± 0.3 4.0 ± 0.4
6.5 ± 0.6 2.2 ± 0.5 2.2 ± 0.5 3.5 ± 0.3 3.3 ± 0.4 3.2 ± 0.4
7.1 ± 0.6 2.0 ± 0.4 1.4 ± 0.2 5.5 ± 0.3 5.2 ± 0.5 3.0 ± 0.5
9.4 ± 1.5 1.5 ± 0.3 1.2 ± 0.2 6.6 ± 0.4 5.5 ± 0.5 5.1 ± 0.3








Table 4. Gelation experimental time values of 2% (w/v) Gel/HA hydrogels depending on 
HRP and H2O2 final concentrations. One of the catalysers was always kept constant to 




In Figure 25, it is visible how pure HA and all Gel/HA hydrogels are transparent, whereas 






As it was expected and observed in Table 4, gelation time in the different hydrogels Gel/HA 
2% w/v increased with the proportion of hyaluronic acid in the composition, with time values 
from 5 min (for pure Gel samples) to 10 min (for pure HA samples). Similar time values 
were obtained in other studies (171), which in addition to the values obtained through the 
analysis of the degree of substitution, suggests similar cross-linking and mechanical 
behaviour to the hydrogels synthesized following the same procedure in previous research 
(171, 118, 119).  
HA in CF-KRB solutions is more viscous than Gel at the same weight/volume percentage, 
meaning precursor solutions viscosity hinders catalysers diffusion and slow down the 
gelation process (18, 171). Lower degrees of substitution in HA-Tyr, in comparison to Gel-
Tyr, may be also involved in longer cross-linking reactions.  
As it is reflected in Table 4, gelation times in all compositions were significantly reduced 
when the concentration of any of the catalysers HRP/H2O2 was increased at constant polymer 
concentration. 
Figure 25. Droplets of the different 2% w/v Gel/HA hydrogels (50µL, n=3) were used to 
determine samples cross-linking time. Pure Gel-Tyr (100/0) hydrogels developed a whitish 
hue, becoming translucent, while the rest of the compositions remained transparent. Gelation 





HRP catalyses the cross-linking reaction, oxidizing two tyramine molecules in each cross-
linking cycle, with H2O2 as oxidant co-substrate (239). Increasing the quantity of H2O2 in 
solution reduced gelation time in all samples according to their proportion of HA, following 
a similar trend to the original HRP/H2O2 ratio. In the presence of excess H2O2,  HRP can 
adopt sometimes an inactivated configuration due to excess oxidation (241); despite this, all 
compositions reduced their gelation times each time H2O2 was increased, meaning excess 
H2O2  regarding HRP inactivation was not achieved in any condition. Changes in the cross-
linking time were more sudden in blends with higher HA ratios when using HRP. This is 
caused by an acceleration of the rate of formation of tyramine cross-links (240), which is 
closely related to the quantity of available HRP in the solution.  
Explained from a physical perspective, HRP molecules are evenly distributed inside the 
precursor solution whereas H2O2 molecules are only introduced when the cross-linking 
reaction is required. When HRP concentration is low, H2O2 molecules in diffusion have to 
cover longer distances inside the solution to reach neighbour HRP molecules to start the 
cross-linking process. Provided one HRP molecule can only oxidize two tyramine molecules 
per cycle in presence of H2O2, the cross-linking time in a determined location will be mainly 
dependent on the number of cross-links per unit of time generated by each HRP molecule 
nearby. Therefore, if the number of H2O2 molecules is increased at constant HRP, the rate of 
formation of cross-links in the area won’t be affected. Yet, the chances of H2O2 reaching 
new HRP molecules in other areas of the precursor solution will increase. In the particular 
case of hydrogels with higher contents of HA, whose molecule chains are considerably more 
rigid than gelatin ones, increasing the formation of tyramine cross-links will cause a faster 
obtainment of structural integrity, even at lower diffusion power and cross-linking densities. 
Control of gelation time and precursor solutions of low polymer concentration possess 
several advantages for drug delivery vehicles and injectable scaffold applications. Fast 
gelation times are required for in situ local drug delivery to prevent the diffusion of hydrogel 
precursor solution, drugs and growth factors out of the target site or the surrounding hydrogel 
formation. On the other hand, slower gelation times are desirable in injectable scaffold 
applications for tissue engineering to correctly fit the defect site.  
3D printing systems benefit from precursor solutions of low polymer concentration and fast 
gelation times due to their facility to encapsulate bioactive molecules or cells in the hydrogel 
matrix without losing their physical integrity during printing. In our system, it is necessary 
to use minimum H2O2 concentrations since the remaining H2O2 can induce cytotoxicity 
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effects. H2O2 changes to H2O and oxygen after decomposition via the enzymatic reaction, 
which means it should be possible to obtain high cell viabilities provided that the remaining 
H2O2 in sample is negligible. This can be achieved by optimising HRP/H2O2 ratios as well 
as the number of possible tyramine cross-links without significantly modifying hydrogel´s 
mechanical properties.  
 
Selection of the calibration surface 
To assure a correct calibration, hydrogels wettability and shape were also analysed with the 
help of the optical tensiometer on different substrates, looking for similar characteristics to 
the one we would usually obtain in cell culture multi-well plates, which would be the 
ultimate printing bed of the system. Glass hydrophilic nature produced significant spreading 
issues on samples, which could lead to excessive evaporation and gelation irregularities. 
Plastic petri dishes, on the other hand, generate similar contact angles to parafilm, being both 
hydrophobic surfaces and more convenient for droplet calibration and gelation. Plastic petri 
dishes and cell culture well plates are conventionally made of non-treated clear polystyrene, 
and in theory, they should possess similar wettability properties. Given that, parafilm layers 
make a better candidate since they can be easily adapted to glass coverslips with insignificant 
alterations in the overall surface height, are fungible and sterilisable with UV light, they do 
not need much space in the build platform and some of the printing systems are already 
adapted for their use, making them particularly manageable and effective as printing 






Figure 26. Droplets of precursor solution on different substrates. (a) Glass coverslip, (b) 
plastic petri dish and (c) parafilm. More stable and rounded droplets were achieved in more 
hydrophobic surfaces, which help to maintain constructs physical integrity during the 
printing and cross-linking process.  
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4.3 Flow rate analysis 
Flow rates in laminar flow regimes are dependent on the applied pressure and resistance to 
flow. Resistance to flow includes viscosity, length of the channel, and channel diameter as 
well as nozzle geometry. Tapered nozzle tips, compared to cylindrical geometries, are 
commonly known to produce less mechanical stress on cells as a result of their different 
entrance and exit nozzle diameters, triggering higher-pressure gradients (and flow rates), at 













For the simple case of a Newtonian bioink (flowing index n=1) flowing through a cylindrical 
nozzle, the flow rate can be approximate by the Hagen-Poiseuille law (102): 
                                                                                                                                 
 
 
where Q is the dispensing flow rate (m3/s), ∆p is the pressure drop between the beginning 
and the end of the nozzle tip (Pa), D is the inner diameter of the nozzle tip (m), η is the 
dynamic viscosity of the bioink (kg/(m·s)), and L is the length of the nozzle tip. For tapered 
nozzle geometries otherwise, the flow rate may be expressed by (96): 
 
Figure 27. Geometry of the different types of nozzle tip: chamfered, general-purpose and 
tapered. The only apparent difference between chamfered and general-purpose tips lies in 
the shape of the tip exit. While general cylindrical tips only possess a polished finish, 
chamfered tips are designed with a special outer diameter taper, reducing the surface area 






where Di and Dt  are the nozzle entrance and exit diameters respectively. The effect of nozzle 
geometry (cone-half angle θc) is evident on flow rate, and in the case of non-Newtonian 
fluids with shear-thinning properties (n<1), increments are even more accentuated. Thus, in 
situations where the extrusion pressure is limited, tapered nozzles result advantageous for 
achieving a higher volumetric flow rate, particularly when dispensing highly viscous 
materials. Poorly viscous inks, however, do not require high-pressure levels for their 
dispensing and may find some significant alterations in flow rate when small pressure 



















Figure 28. Experimental flow rate values from buffer precursor solution through the 
different 25 G nozzle tip geometries. (a) Influence of the total volume of solution in the 
cartridge and (b) pneumatic pressure, and their relative values (c) and (d) respectively to 
the minimum flow rate found in the entire assay (chamfered, 4 kPa, 1 mL). Dispersion in 
data is represented as the time lag during the printing process. Significant differences (*) 




To analyse the influence of pressure, the CF-KRB buffer precursor solution (η≈1 mPa·s-1) 
was extruded through different nozzle geometries with the same gauge and tip length. 
Pressure influence was reflected by means of two different factors, the resultant pressure 
from the application of pneumatic pressure of the printing system (Papplied), and the 
hydrostatic pressure resulting from the own bioink weight inside the cartridge reservoir  
(Vsol).  
From Figure 28 is possible to infer some main ideas. First, as we had already foreseen from 
literature, tapered geometry triggered flow rates with at least a 4- to 5-fold increase compared 
to the rest of the nozzle tips. Although pressure influence is visible in all the nozzles, tapered 
tips seemed to be more sensitive to pressure changes at low viscosity generating greater 
differences in flow rate between conditions as well as bigger dispersions inside each 
condition. Significant differences in pneumatic pressure can be problematic in systems 
where pressure resolution is not ideal. In our case, pressure´s resolution was 1 kPa, sufficient 
for fluids with higher viscosity or droplet-based modalities, but rather difficult to operate 
with water-like consistency inks and when requiring accurate volume dispensing as it is 
proven in Figures 28 and 29. Dealing with significant differences in the volume of solution 
also becomes a challenge, increasing calibration´s difficulty as well as its time when larger 
precursor solutions are required. Moreover, higher pressure gradients are responsible for 
longer time lags (data dispersion), increasing volume dispensing inaccuracy at faster printing 










Figure 29. Flow rates values in 25 G chamfered and general-purpose tips, both cylindrical.  







Flow rate in cylindrical tip geometries (general-purpose and chamfered), also seemed to vary 
between conditions, but pressure influence was found significantly smaller. Moreover, data 
dispersion was negligible, generating very low time lags during printing, especially in 
chamfered tips. Slightly higher viscosities should provide more stable droplet dispensing, 
however, temperature influence in this project was not assessed given the incredible amount 
of already processed parameters.  
To complete the analysis, a regression line for each data set was calculated as a way of 
measuring flow variability when either printing pressure or volume of solution was modified. 
Pressure and printing times in this experiment were intended to reduce volumetric artefacts 
as much as possible, as well as the ink´s dependency on viscosity as a result of temperature 
differences at the nozzle exit. Tapered nozzle tips possessed the biggest gradient index in 
both factors, being maximum when solution volume was changed and therefore no longer 








Chamfered and general-purpose tips possessed similar levels in both flow gradients, 
however, chamfered tips possessed lower data dispersion, grip issues and flow rate 
variations, making them adequate for their use in microdot applications for very poor viscous 
bioinks. 
In conclusion, the use of tapered nozzle tips, although being generally more beneficial for 
cell survival, could be particularly counterproductive for this printing protocol because of 
the strong pressure influence on flow rate involved during the printing process and its 
Figure 30. Flow gradient in the different 25 G nozzle tip geometries. Flow gradient 
experimental values can be expressed as a parameter of flow variability when changing 
one of two factors. Significant differences denoted as (*) for p ≤ 0.05. 
81 
 
possible negative effect on cross-linking dispense. When selecting a cylindrical nozzle, 
choosing an adequate tip diameter will be the more efficient way to control and operate with 
particular flow rates as well as assuring an unharmful effect on cell survival. Besides, in 
thermoresponsive inks such as gelatin, controlling the printing temperature not only at the 
syringe or cartridge barrel but also at the printing tip, will be crucial to ensure a constant 
flow rate. In that case, tips with shorter lengths and bigger diameters (G < 25) will be more 
advantageous to diminish pressure and viscosity’s influence during printing when resolution 
is not a key requirement. 
 
4.4 Density and viscosity approximation. 
Parameters such as the Reynolds number (Eq. 4) or cell sedimentation rate (Eq. 7) are highly 
influenced by the solution density and therefore needed to be calculated for posterior 
analysis. Density values from Table 5 were obtained from Eq. 1 and Eq.2 for the different 
polymer blends and different polymer concentrations in solution (w/v) (%). The density 
value established for all the following calculations was from pure Gel solution at 2% (w/v), 
since it was found to be the maximum value of all the polymer series studied in this project. 
However, as it is noted, solution density does not change much when either increasing 










The viscosity of the different hydrogel precursor solutions obtained in Table 6 was a key 
parameter involved in the calculation of different variables including the Reynolds number, 
shear stress, pressure drop and cell sedimentation. Given the impossibility of using some 
equipment for material characterisation during the pandemic, apparent viscosity at low shear 
Table 5. Theoretical density values of Gel/HA hydrogel solutions at different polymer 






rates could not be directly measured by a rotational or shear rheometer. Instead, viscosity in 
the different solutions was predicted using Hagen-Poiseuille’s flow equation (Eq. 3) and the 
applied pneumatic pressure ((Papplied) during printing, assuming poor frictional forces due to 
viscosity. According to this equation, the existing delta of pressure (∆p) found in the barrel 
from the surface of the plunger to the nozzle exit is directly proportional to the fluid’s 
viscosity and flow resistance. When using small constant flow rates and same nozzle 
geometries, pneumatic pressure can be then approximate to the pressure drop inside the 
barrel, and therefore viscosity for every solution blend could be estimated.  
 
Due to the high molecular weight of HA, solutions with higher proportions were expected 
to possess higher viscous properties, leading to the use of greater levels of pneumatic 

















Table 6. Approximate theoretical values of viscosity of the different 2% (w/v) Gel/HA 
hydrogel precursor solutions at printing temperature (37 °C). Given the values of pneumatic 
pressure applied (Papplied) and flow rate (Q) for droplet dispensing, estimated viscosity 
intervals could be obtained by the application of the flow Hagen-Poiseuille equation (Eq. 3) 
in which is possible to calculate the pressure drop (∆p) inside a cylindrical needle. 
Influencing parameters such as volume of solution, tip geometry, temperature and flow rate 
were constant during the assay. Rest of parameters normally included in fluild´s resistance 
to flow (viscosity changes, friction coefficient or wall-piston friction) were considered 




1 4,8 100/0 10-11 1,5-2
1,5 7,2 70/30 12-13 2-2,5
2 9,6 50/50 15-16 2,5-3
2,5 12,0 30/70 17-19 3-3,5













































Figure 31. (a) Reynolds numbers, (b) theoretical shear stress and (c) pressure drop values 
for 23 G (Ø 330 µm), 25 G (Ø 250 µm) and 27 G (Ø 200 µm) cylindrical nozzle tips. 
Values are dependent on solution viscosity η (mPa·s) and flow rate Q (µL/s). Shear stress 
values for the different nozzle gauges (ηGel/HA (37 ºC) = 2 – 5 mPa·s (red), Q = 10 – 20 µL/s) 
were significantly lower to the pressure threshold (< 5 kPa) visibly harmful for fibroblast 
cells obtained from literature, meaning no differences in cell viability should be found 
regarding the effect of mechanical stress. Tip diameter influence is obvious on the printing 
pressure. According to the Hagen-Poiseuille equation (Eq. 3) and as shown in the graphs, 
the pressure drop inside the needle will increase by a factor of 16 (i.e. ∆p ~ D-4) decreasing 





a)                                       b)                                             c) 
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Evolution of Reynolds numbers, shear stress and pressure drop for the different nozzle 
diameters in function of the viscosity and flow rate were calculated following Eq. 3 to Eq. 5 
as shown in Figure 31.  
Motion of fluids is notoriously hard to predict. The Reynolds number (Re), with the property 
of being dimensionless, plays an important role in foreseeing the patterns in a fluid’s 
behaviour through cylindrical conduits (e.g., nozzle tips) which can be normally categorized 
as laminar (Re < 2100), turbulent (Re > 4000) or something in between (2100 < Re < 4000).   
As it was already mentioned in the introduction, velocity profiles in laminar flows are stable 
and parabolic across the conduit diameter, finding the maximum shear stress at the barrel 
and nozzle walls. In this case, maximum shear stress can be easily calculated from the 
Hagen-Poiseuille´s flow equation (Eq. 3) as described in Eq.5. Reynolds number for the 
different nozzle tips was confirmed to be Re < 2100 for viscosities from η = 1 – 10 mPa·s. 
Materials with higher viscosities (η > 10 mPa·s), either caused by their polymer density or 
variations in temperature, will acquire lower Reynolds numbers provided the use of adequate 
flow rates, ensuring laminar behaviour.  
Shear stress levels, on the other hand, gradually increased when either increasing viscosity 
or flow rate, however, the selection of the nozzle diameter became the most determinant 
factor to ensure appropriate levels of cell stress (< 5 kPa). Although higher gauges presented 
considerably lower tolerances to the sudden increase in any of both parameters, all hydrogel 
precursor solutions should be safe to print through 23 G, 25 G, 27 G nozzles at physiological 
temperature (ηGel/HA (37-39 ºC) = 2 – 5 mPa·s). Due to the thermo-responsive properties of 
Gel and HA, viscosity in the different precursor solutions was expected to dramatically 
increase when decreasing the printing temperature, augmenting in turn the levels of shear 
stress (Figure 32). When these changes in temperature are inevitable or cause abrupt 
distortions in the viscosity of fluids, the use of lower gauges or tapered geometries can 
diminish any harmful effect on cells, protecting them from mechanical forces within the 
solution. Even though none of the Gel/HA hydrogel samples required high printing 
resolutions given the simplicity of their shape profiles, it was still considered interesting for 
the project to determine the limits of safe shear stress at high gauges (Ø 250 – 200 µm) in 
the event of working with more complex and precise architectures for future applications. 
Pressure drop was found the most sensitive parameter to changes in viscosity, being strongly 
dependent on the nozzle diameter and connected to the bioink’s resistance to flow. From 
Figure 31 it was possible to infer some general ideas.  
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It is worth stressing how polymer density in some bioinks can substantially enhance the 
influence of small nozzle diameters on pressure drop. Polymers, such as the case of Gel or 
HA, can hold severe fluctuations in viscosity when their solution density (w/v (%)) is just 
increased by a few times. Gel solutions at 5% w/v, for instance, possess similar viscosities 
at 40ºC to the obtained in this project (η < 10 mPa·s), but can easily reach viscosities up to 
1000 mPa·s when temperature decreases to 20ºC, meaning a 100-fold increase compared to 
the estimated viscosity (η(20ºC) < 100 mPa·s) of Gel/HA hydrogels at 2% w/v (249). Higher 
Gel densities (10%-30% w/v), generally more attractive for 3D bioprinting due to their good 
fluid behaviour during printing, can simply display viscosities of  400 < η < 1300 mPa·s at 

















Depending on the quality of resolution desired for each application, some current 3D 
bioprinters on the market may face physical limitations in terms of pneumatic pressure (P > 
400 kPa) (251) when using very fine needles alongside high enough viscous bioinks. To take 
Table 7. Effect of bioink’s viscosity on shear stress and pressure drop at Q = 10 µL/s at 
different cylindrical nozzle gauges. Above, shear stress levels and pneumatic pressure 
requirements (low, medium, high) according to literature. Below, comparison table for 
theoretical shear stress and pressure drop values regarding bioink’s viscosity when passing 







an example, the popular CELLINK’s Benchtop Bio XTM and X6TM bioprinter devices (252), 
well-known for the application of very promising hydrogel bioinks, possess an internal oil 
pump merely capable of reaching 200 kPa of pneumatic pressure, whereas in the company 
of an additional external air compressor can go up to 700 kPa. From Table 7 we can easily 
deduce how some of these pressure levels will be insufficient for applications where 
viscosity reaches η > 100 mPa·s in any of the mentioned nozzle diameters.  
Furthermore, many cartridge heaters do not normally cover the surface of the nozzle tip, 
generating lower temperatures at the nozzle exit. Bioinks with abrupt changes in viscosity, 
as a direct consequence of small changes in temperature, tend to suffer from important 
variations in flow rate during printing, leading to the continuous modification of the 
pneumatic pressure and ultimately to printing failure. Sudden increases in viscosity can also 
lead to probable clogging issues where the accumulation of high pressures inside the barrel 
can be eventually responsible for cell damage and much longer printing times. 
In the case of our 2% w/v Gel/HA hydrogel solutions, 25-27 G nozzles so far presented 
significant variations in pressure when viscosity was incremented or decremented by a few 
units affecting flow rate and requiring precise optimisation processes before and during 
printing. 
In summary, due to the high values in shear stress and required pneumatic pressure in 27 G 
cylindrical nozzles, we decided to continue all the following assays with chamfered 25 G 
nozzles, which are still considered good for high-resolution requirements, low-pressure 


































Due to the elevated water content in hydrogels, these materials inherently tend to evaporate, 
even more before the cross-linking process as t as possible using deeply cleaned tips fis 
observed in Figure 32. Water evaporation constitutes a serious risk for the nozzle tip 
(material clogging) as well as for the structure integrity (irregular flow rates) and thus it is 
Figure 32. Evaporation rates of the buffer solution and 2% (w/v) Gel/HA precursor 
solutions at room temperature (20-25 ºC). Evaporation rate was found very similar between 
the solvent and the hydrogel solution. The evaporation rate was described as the volume 
loss over time at different droplet volumes. Larger exposed surfaces to the environment as 






recommended to always print as fast as possible using properly cleaned tips for each protocol 
stage. In cell-laden hydrogels, the necessity of retaining the original shape is also 
determinant for the scaffolds success. In this stage of our research, droplet shape was not 
significantly important and samples could be entirely cross-linked before droplet structure 
was irreversibly lost, even when incubated at 37º C. Besides, due to the low polymer density 
of our precursor solutions, even in the event of material clogging, bioinks could be 
effortlessly reheated for a few minutes and managed to print again without compromising 


















































Table 8. Theoretical values of cell sedimentation rate at different solution viscosities 
based on Eq. 7. Minimum number of 10µL, 25µL, 50µL droplets dispensed per minute 
were calculated based on cell sedimentation speed and the total distance (top-bottom) of 
1mL solution  in the cartridge barrel. Tolerance was set in maximum increment of 25% of 
the original cell density at the cartridge bottom (500 µL). Using the viscosity interval for 
each hydrogel precursor solution, it is possible to establish a reference droplet dispensing 
rate. Decreasing  bioinks volume or hydrogels viscosity will directly increase the total 






10 µL (n) 25 µL (n) 50 µL (n)
100/0 2-1,5 12-9 4-3 2-1
70/30 2,5-2 9-7 2-3 1
50/50 3-2,5 7-5 2 1
30/70 3,5-3 5 2-1 1




minimum samples / min
When the solution density is lower than the density of the cellular components inside it, cells 
tend to sediment as a result of gravity. Cell sedimentation in this project for both modalities, 
extrusion-based and droplet-based, was a concerning factor given the poor viscous properties 
of 2% w/v Gel/HA hydrogel precursor solutions (Tables 8 and 9). Elevated cell 
sedimentation rates are generally related to clogging issues at the nozzle exit causing 
eventual printing failures. Cell sedimentation rates were calculated for all Gel/HA 
compositions according to the approximate intervals of polymer density and solution 
viscosity presented in Tables 5 and 6. The minimum number of samples per minute needed 
to avoid significant effects of cell sedimentation in sample were also calculated for different 
sample volumes, with a  maximum tolerance of 25% cell density increment in the lower half 
part of the bioink solution inside the cartridge. Temperature plays an essential role in 
reducing cell sedimentation given its power to suddenly increase fluids viscosity without 
producing any negative effect in cell viability when used for small periods. Based on Eq. 7, 
bioinks with minimum viscosity η > 20 mPa·s, even at very low polymer density, could be 
















Table 9. Reference droplet dispensing rate for the different 2% w/v Gel/HA hydrogel 
precursor solutions depending on the approximate viscosity values obtained in Table 6.  
Minimum number of 10µL, 25µL, 50µL droplets dispensed per minute in 1mL solution 
in the cartridge barrel. Tolerance was set in maximum increment of 25% of the original 






4.8 Standoff distance calibration 
We tested the generation of cross-linked hydrogel samples (droplet formation and cross-
linking processes) employing the two available bioprinting strategies, extrusion-based and 
droplet-based bioprinting. The standoff distance, the distance that exists between the nozzle 
tip and the printbed, is commonly known in bioprinting for its relevant influence on the 
formation of accurate and stable samples.  




















The height of different droplet volumes was analysed by a Theta optical tensiometer and 
ImageJ software. Afterwards, groups of droplets (n=15) with different volumes were 
Figure 33. Calibration of the standoff distance for droplet formation through extrusion-
based printing modalities using chamfered 25 G nozzles. (a) Droplet heights for 1-5 µL and 
(b) 10 – 50 µL droplet volumes and their recommended printing distance (green area) 
compared to the ones established by literature (2Dn – πDn). Incorrect distances affect droplet 
shape as well as the ejection pressure. Longer SD are controlled by the capillary rise effect 
and bioink’s wettability, producing very unstable droplets. Flow rates in shorter SD are 






extruded at different standoff distances, analysing possible shape variations in each set. 
Correct working standoff distance intervals were considered the ones with no influence on 
flow rate, which allowed an accurate dispense of the bioink onto the printbed without shape 
distortions. Recommended standoff distance intervals for droplet formation (1-50 µL) by 
extrusion were consequently established between one and two times the nozzle diameter 
(Dn, 2Dn) (Figure 33), selecting as an optimal distance value the one around half the height 
of each droplet size group.  
4.8.2. Cross-linking injection (extrusion-based printing) 
Similarly to the analysis of droplet formation, standoff distance for the injection of the cross-
linking solution was studied by the assessment of cross-linked samples at different nozzle 
heights. Given the high probability of appearance of uneven droplet profiles or the 
occasional printing of droplets of different volumes during the same process, the correct 
















Figure 34. Schematic diagram of standoff distance calibration for cross-linking injection 
for different droplet volumes (left) and similar droplets with uneven shapes (right). Some 
3D bioprinters allow setting a single standoff distance for each layer deposition of a printing 
process. Samples with different volumes or uneven shapes can possess significant 
differences in height, which can lead to the cross-linking failure of some of the hydrogel 
samples. It is therefore important to determine the working intervals for each possible 






Eventually, recommended standoff distance for each droplet group (n=15) was set up in 70% 
of the minimum height obtained for each set (Figure 35), assuring in that way that the nozzle 
tip always reached the droplet surface regardless of its profile.Similarly, these values provide 
a correct diffusion mechanism of the cross-linking solution going from the upper part 
through the rest of the sample by means of the effect of gravity.   
The contact of the nozzle tip with Gel/HA hydrogels during the cross-linking involved the 
possibility of nozzle clogging and the injection failure in the successive samples. This could 
be solved by simply exchanging the nozzle tips during the process and assuring a correct 



















Figure 35. Calibration of the standoff distance for cross-linking injection in extrusion-
based printing modalities using chamfered 25 G nozzles. (a) Recommended distance for 
the cross-link addition in 1-5 µL and (b) 10 – 50 µL droplets based on their 70% of the 
minimum volume height (triangle). Values around these distances guarantee an 
appropriate cross-linking administration. Longer distances than the established may not 
reach the target surface, reducing the chances of a sample being cross-linked, and shorter 
ones may deposit the cross-linking solution (or part of it) in the lower part of the droplet, 






4.8.3. Droplet and cross-linking ejection (droplet-based printing) 
The generation of droplets, as well as the addition of cross-linking, were also tested in a 
micro-valve printing system (droplet-based technology). Both protocol stages were totally 
























Figure 36. Calibration of the standoff distance for droplet deposition and cross-linking 
ejection in droplet-based non-contact printing modalities (micro-valve). Droplet volume 
is regulated by the standoff distance, the valve opening time topen as well as the pneumatic 
pressure. Shorter standoff distances (<< SD) and excessive pressures can cause distortions 
in the droplet shape or even its destruction. Longer distances (>> SD) and deficient 
pressures, on the contrary, may end up in droplet deviation and fragmentation, where 






Due to the very low viscosity of the studied bioinks, droplet formation was easily achieved 
through the calibration of the standoff distance and the number of shots, which defines the 
number of droplets ejected per each single deposition point (described in point 4.9).  
Micro-valve systems, due to the absence of a nozzle tip, tend to suffer from cross-
contamination in multi-step protocols and thus they normally require a complete cleaning 
process of the printing valve between steps (different solutions). In the particular case of 
enzymatic cross-linking, the lack of cleansing can cause several clogging issues at the 
nozzle, attributable to the reactive rests of polymer fibres alongside enzymes inside the 
nozzle that enter into contact with the cross-linking solution. Our system, counting with only 
one micro-valve printhead, implicated longer printing times when performing both protocol 
steps (droplet formation and cross-linking) with the same technology compared to the 
extrusion-based system, increasing the chances of cell sedimentation and cell cytotoxicity in 
samples as well as the loss of the desired shape. Hence, and provided the obvious advantages 
that present any non-contact technology, micro-valve printing for this project was decided 
to be used solely for the step of cross-linking, being also the one selected for all the cross-
linking stages in cell culture assays.  
As it is observed in Figure 37, droplet volume remained practically stable (± 1 µL) with the 
increase of pneumatic pressure, providing evidence of its weak influence in this system as 
well as the one resulting from the solution weight. On the other hand, standoff distance, 











Figure 37.  Calibration of standoff distance (3 – 9 mm) in micro-valve printing for 
different pneumatic pressure, topen = 80 ms (Ø 300 µm) and shots = 1. Pressure resolution 
(± 1 kPa). Some configurations generated unstable droplets (red) due to the inadequate 
level of pressure or distance to the printbed. Droplet volumes, unlike in extrusion 








4.9 Bioprinting protocol design 
Once all the important physical parameters involved in the bioprinting process were analysed 
and adjusted, it was time for the design and calibration of the spatial coordinates of the 
complete protocol, in other words, it was the time to establish beforehand the exact location 
of every single droplet or cross-linker deposition on the printbed, which is normally 
described as a set of coordinates (x,y,z axis) in a 3D cartesian system.  
Our protocol was designed based on similarities to the already existing manual protocol of 
hydrogel gelation. In such protocol, Gel-Tyr/HA-Tyr solutions including cellular 
components and HRP, are firstly formed on the substrate or multi-well plate by precise 
deposition with the help of a micropipette. Afterwards, the cross-linking solution including 
H202 is added on top of each droplet or introduced inside, mixing gently then both solutions 
if desired for a more homogeneous reaction. As we already mentioned during the 
introduction, micropipettes directly provide the dispensing of accurate volumes previously 
set by the user, which seldom occurs when working with printheads. All parameters involved 
in the simple deposition of a single hydrogel sample by hand (volume, pressure, time 
employed, distance to the surface, pipette tip, sample location) are chosen and easily adjusted 
at will by the user at the moment of pipetting. In 3D automated systems, a digital model 
similar to the popular sketches from CAD software is processed by software tools that slice 
and translate it into a set of coordinates and functions describing the deposition pattern(s) 
followed by the printhead(s), the order in which they are printed, and the location of each 
deposition point. The data are then loaded into the 3D bioprinter, where some parameters 
such as pneumatic pressure, cartridge temperature or the initial standoff distance can be 
modified before, during, and after the printing process thanks to the user-friendly operational 
interface generally included in the printing device. 
Standoff distance in the Biosafety 3DDiscovery™ Evolution bioprinter is conceived slightly 
differently from its physical concept (Figure 38). While in physical systems, standoff 
distance and nozzle height refer to the same concept (distance from the substrate to the 
nozzle tip), some working systems operate with the original length of the nozzle tip as a 
nominal value after an automated process of calibration, representing the distance zero point 
from the nozzle tip to the substrate (SD = 0).   
Apart from the general standoff distance, the system also counts with other useful parameters 




















Important parameters in the Z-axis inside protocol design (3DDiscovery™) 
Lift nozzle (HL): Distance in mm from the current printing layer in the Z-axis. The printhead 
will lift the tip or nozzle to this point every time printhead needs to travel around the 
workspace without dispensing.  
Safe position (HS): Distance in mm from the build platform in the Z-axis. The printhead 
will lift the tip or nozzle to this point when the system executes a tool change or/and after 
printing completion. 
Shots: Depending on the system, it can refer to the number of seconds pressure that will be 
applied when printing (extrusion bioprinting) or the number of droplets to dispense at a 
unique point of the platform (micro-valve). 
Needle length (Hn or Ln) or standoff distance (SD): Distance in mm from the base of the 
tip or nozzle to the build platform in the Z-axis. It is necessary to be set prior to any 
deposition process. When calibration occurs, needle length will reach its nominal value, 
being always different from zero. In the case of requiring a minimum standoff distance or 
Figure 38. Representation of the standoff distance in different systems according to the 
centre of the cartesian coordinates (Z axis). Whereas in physical or mathematical models, 
standoff distance is described as the distance between the tip and the printing substrate or 
the needle height from the printbed (SD = hn), some 3D printing systems work with nozzle 
nominal lengths (Ln0 ≠ 0) placing the origin of the coordinate system at the base of the 
nozzle tip, not on the printbed substrate. Longer standoff distances are achieved by the 






needle height, needle length can be manually adjusted, where the new needle length will be 
the sum of its nominal value and the added distance between tip and substrate. 
The bioprinting protocol was designed in three separated phases: droplet size calibration, 
protocol testing with incorporated cells and the ultimate bioprinting protocol for cell culture 
assays (Figure 39). Droplet calibration and protocol testing were performed on parafilm 
substrates, a surface similar to the bottom of the wells in non-treated culture plates. Standoff 
distance (Hn1 // Ln1 ) for the formation of droplets was decided based on Figure 35 using the 
extrusion printhead. Once droplet calibration in the first part was successful, protocol testing 
included the adjustment of a second standoff distance (Hn2 > Hn1 // Ln2 > Ln1) for cross-
linking dispensing using the micro-valve system and the collected data in Figure 35. (1) 
Droplet and (2) cross-linking location for each sample possessed the same (x,y) coordinates, 
only differing in their standoff distance (z) and printing order.  Lift nozzle (HL) and safe 
position (Hs) were set at least at 30 and 50 mm respectively for both phases. After a couple 
of assays with effective hydrogel gelation, cellular components were included in the bioink. 
Once cross-linked hydrogel samples could be detached from the substrate as a single 
structure, they were transferred to a culture multi-well plate, cultured for a few days, and 
analysed. 
Ultimate bioprinting protocol additionally included the geometry and depth of each cell 
culture plate well as the new printbed substrate for the different samples. Without a correct 
adjustment of each well centre position (x,y), droplet formation or cross-linking ejection was 
unstable and unpredictable. All parameters in the Z-axis in this final part of the design had 
to consider the additional thickness of the bottom of the multi-well plate (D) as well as the 
total height of the plate (C), regardless of the plate model. Therefore, standoff distances Hn1 
and Hn2 increased to Hn1 + D and Hn2 + D, and safety height parameters HL and Hs to HL+ C 



































Figure 39. Stages of the bioprinting protocol design: droplet calibration with no 
cellular components, cell printing for its testing and optimisation, and final bioprinting 
protocol in cell culture well plates. Parameters of interest in the Z-axis are Hn, HL and 






4.10 Cell culture studies  


























Figure 41. Optical microscope image (10x) of cells C2C12 in a Gel/HA hydrogel at 4 
days of culture. Cell population outside the hydrogel is a product of the sedimentation, 
migration and detachment from the material. Cells behaviour denoted a good proliferation 





Figure 40. Brightfield images of the different Gel/HA compositions at 4 days of culture. 
Scale bar is 200 µm.  Notice the difference in cell morphology from totally spread in pure 
Gel-Tyr to globular shape in pure HA-Tyr depending on the available number of adhesion 
domains found in the substrate. Spread cell morphologies and highly dense cell 
populations may be difficult to count with the Live/Dead staining in longer periods, due 
to the entire permeation of Calcein-AM in cells cytoplasm. Only rounded shaped cells 
could be easily detected in posterior assays. 
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Cell viability and density were measured by the analysis of Live/Dead assays as well as some 
visual parameters such as cell morphology and behaviour. Due to the diverse number of 
available binding domains between Gel and HA, initial cell cultures performed both by hand 
and 3D printing presented different cell morphologies between compositions after 4 days of 
culture (Figure 40) as previous studies had already shown (32). A tendency to sediment and 
detach from the hydrogel was also observed in all conditions (Figure 41) where hydrogels 
with higher proportions of Gel denoted higher numbers of cell detachment. Cell detachment 
and later adhesion to the bottom of the well plate was seen as a positive indicator since it 
suggested good cell viability and weak cytotoxicity during the cross-linking process. 
Samples cultured under contamination during incubation or cytotoxic processes of 
encapsulation presented no cell detachment or proliferation in any condition. These samples 

















Figure 42. Viability assay of C2C12 cells in control 2% (w/v) Gel/HA hydrogels (50µL, 
n=3) after 3h and 4d of culture. As indicated by the two-colour fluorescence dyes, living 
cells (calcein-AM, green) and dead cells (EthD-1, red). Scale bar is 200 µm. a) Cell 
viability percentages, defined as the ratio between live cell count and total cell count, b) 
approximate cell density values in the different hydrogels. Symbol (*), denotes 
significant differences with p<0.05. All hydrogel compositions presented similar viability 
values. However, cell densities decreased with higher HA contents probably due to 




Control and printed samples in multiple assays (Figures 42 and 43) presented highly similar 
cell viabilities, denoting no apparent shear stress or chemical cytotoxicity during the printing 
process. Hydrogel compositions, as expected, presented an overall decreasing trend with 
regard to their cellular densities depending again on the available binding domains of Gel 
and HA, finding always the minimum cell density in pure HA hydrogels. Cell density in 
general, although expected to be higher after a few days of culture, appeared to be 
significantly lower in some of the assays. However, as it was previously commented, packed 
and spread cells were difficult to recognise by Live/Dead assays through a fluorescence 
microscope, attributable to the penetration of Calcein-AM into the entire cell cytoplasm. The 
use of nuclei staining was limited for this type of assays since nuclei dyes may result 
cytotoxic when used in big enough quantities. Besides, due to the probable event of cell 
detachment (cell loss) after seeding, densities were likely higher than the observed. Cell loss 
during printing alongside cell sedimentation could also explain the overall lower cell density 
in printed samples compared to controls in both time points, as cells may have attached to 
the cartridge-needle walls during the extrusion process and then to the bottom of the well 
plate, another supporting idea of the nonexistent cell damage during deposition. 
Hydrogel peroxide (H202) acts as a co-substrate for HRP-catalysed cross-linking reactions. 
H202 is one of the major members of reactive oxygen species (ROS) and plays an essential 
role as a beneficial signalling agent (253-257) or a cytotoxic hazard in physiological and 
pathological processes (258-266). This molecule has been extensively studied for its 
participation in some metabolic pathways of cancer cells (267), given its natural secretion 
during chronic inflammatory responses. Oxidative stress generated by externally added H202 
induces stress-induced premature senescence (SIPS) in a variety of cell types (268-270), 
being one of the most important causative factors for the induction of cell apoptosis.High 
concentrations of this molecule have proven to be highly cytotoxic, depending on the cell 
type’s sensitivity to oxidate stress, cell concentration, the ability of these to eliminate H202, 
the used volume of medium as well as the exposure time (258,259).  
Differences in the cell concentration likely contribute to the large variation found in the 
cytotoxic concentrations of H202 reported in numerous papers. Such differences, nonetheless, 
are very difficult to determine, as relevant information on cell density and culture medium 
volume most often are not published. For instance, studies in gingival fibroblasts 
demonstrated how SIPS could be induced by a concentration of H202-treatment as low as (> 
20 µM) when compared to other types of fibroblasts (271). However, H202 under subtoxic 
concentrations has also been demonstrated to induce a higher proliferative activity in human 
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dorsal fibroblasts, rabbit lens epithelial cells, baby hamster kidney fibroblasts and embryonic 
Chinese hamster ovary fibroblasts (256, 259, 272, 273). Apart from this, H202 is known to 
cause degradation/depolymerization of various polymers at relatively high concentrations 
and long exposure times, including Gelatin (310), HA (311,312), or even other Gelatin 
grafted with phenol moieties (Gel-Ph) hydrogels (313). 
Different supplementation of culture medium with antioxidants and precursors (274,275), as 
well as different contents of peroxide-consuming additives in the culture medium like 
pyruvate (276,277) or serum albumin (278) found in fetal bovine serum (FBS), have also 
been oarthritic chondrocytes in synovial fluid under oxidative stress, redshown to increase 
the ability of some cell types to eliminate H202 during culture (258). Likewise, some studies 
have pointed out the ability of HA to protect human osteoarthritic chondrocytes in the 
synovial fluid under oxidative stress, reducing the levels of hydrogen peroxide and 
superoxide (O2) in patients with knee osteoarthritis via multiple intracellular regulations, 
including anti-oxidation, anti-apoptosis, promotion of protein synthesis, and cell survival 
(279).  
There are several documented research studies assessing the effects of H202 on cell 
proliferation and survival of C2C12 cells (280-285), some of them presenting cell death at 
H202 concentrations as low as 100 µM at cell densities of 5 x 10
4 cells/cm2 (280) or inducing 
atrophy and loss in myoblasts myotubes at 1mM for 24h culture (282). Despite this, our 
system decomposes H202 molecules into H20 as part of the HRP-catalysed cross-linking 
reaction, and hence the possible cytotoxic effects of hydrogen peroxide in enzymatically 
cross-linked Gel/HA systems may greatly differ from other cell culture models, even when 
using the same cellular line. Additionally, due to the high concentration of C2C12 cells used 
in each hydrogel (4 - 8x106 cells/mL) alongside the elevated volumes of medium, sometimes 
including 20% FBS, effects of H202 on cells could be even milder than expected. In order to 
study the possible cytotoxic effects of inaccurate cross-linking dispense (higher H202 
concentration) as well as its study for potential applications in drug testing, cytotoxicity 
assays were performed in printed cross-linked hydrogel samples in presence of higher H202 
concentrations (3mM, 4mM and 5 mM), 30 to 50 times the minimum toxic concentration 
determined in previous studies (280).  
From Figures 43 and 44 it is possible to infer that the increase of H202 concentration up to 
5 mM in the cross-linking solution did not produce significant variations in cell viability due 
to any cytotoxic hazard. Some compositions even presented higher cell densities than their 
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regular printed samples, probably because of an increase in the cross-linking density that 
produces hydrogels to be less swollen, in other words, to be more compacted. We 
hypothesise that when the cross-linking solution is diffused through the hydrogel precursor 
solution, HRP and phenol moieties immediately react with the H202 molecules nearby, 
decomposing them into H20 and preventing them from interacting with cells. The remaining 
H202 is then eliminated by the very same cells in culture after a short time. Pure HA 
hydrogels, as the composition with the lowerest degree of tyramine substitution, could be 
the one more affected by H202 increment, however, presented similar cell viability and 
density values to the regularly printed samples. 
Calcium-free Krebs Ringer buffer (CF-KRB) is a solution of several salts dissolved in water 
which proportions vary from species to species, to create an isotonic solution relative to the 
body fluids of an animal. A salt solution’s basic function is to maintain the pH and osmotic 
pressure balance in the medium resembling the blood serum in its salt constituents, as well 
as provide the cells with water and essential inorganic ions for correct cell functioning. Krebs 
Ringer’s solution is frequently used in in vitro experiments on organs or tissues such as in 
vitro muscle testing (286-288). CF-KRB also possesses good flow perfusion, facilitating the 
flow of H202 molecules throughout the hydrogel precursor solution. Despite this, CF-KRB 
participation in the cross-linking of Gel/HA hydrogels in other projects demonstrated to be 
fairly high cytotoxic when using particular cell types, as is the case of primary human 
hepatocytes (286). Hepatocytes viability in synthesised Gel/HA hydrogels with CF-KRB, 
presented a dramatic decrease after 1 day of culture (20% cell viability), becoming almost 
inexistent (0,5%) after 7 days. In our project, although several successful results were 
obtained when using the CF-KRB solution in C2C12 cells, truth is that there were also 
numerous discarded assays with similar results. Cells in contact with CF-KRB solution for 
long enough times (t > 15-20 min) resulted in general in very low initial cell viabilities, 
generating hydrogels with no cell proliferation or cell detachment from samples during the 
following days. We strongly recommend the use of alternative buffer solutions for 
prospective assays, given the large quantity of discarded samples we faced during this 
project combined with the time employed for the preparation of each 3D printed deposition 




































Figure 43. Viability assays of cells C2C12 in 2% (w/v) Gel/HA hydrogels at different 
time points (3 h, 1d) and conditions (control, 3D printing, 3D printing + 5mM). Samples 
were formed and cross-linked by hand or by printing automated process to assess the 
influence of mechanical stress and possible contamination during deposition. Scale bar is 
200 µm. Cell viability at (a) 3h and (b) 24h culture. Cell density at (c) 3h and (d) 24h 
culture. Samples at higher H202 molarity (5mM) were included in the 3D printing protocol 


































Figure 44. Cytotoxicity assay of cells C2C12 in printed Gel/HA 70/30 and 30/30 hydrogels 
at (a) 3h, (b) 1d (5mM) and (c) 4d of culture and their respective cell densities (d-f). 
Samples were printed with higher H202 concentrations in all samples from 3mM to 5mM 





4.10.2 Cell adhesion and morphology 
Once cell viability in Gel/HA hydrogels was demonstrated to be successful up to 4 days of 
culture by our designed 3D printing protocol, cell morphology and adhesion were studied 
after 7 days of culture to ensure correct cell proliferation and adhesion over longer periods 
(Figures 45 and 46).  
Assays were performed in different hydrogel compositions and culture conditions, including 
differentiation medium at higher cell concentration. The cell line of C2C12 cells possesses 
very short periods of differentiation, being perfect for their study and analysis. Cell adhesion 
and morphology were also evaluated in hydrogels cross-linked at different H202 molarities, 
in order to continue with the assessment of the possible cytotoxic effects presented in cells.  
Higher cross-linking densities are usually responsible for modifications in the hydrogel pore 
size and pore interconnectivity, swelling ratio, hydrogel stiffness and hydrogel degradation 
rate among others. Increasing either or both of the two catalysers (HRP/ H202) decrease the 
time required to gain structural integrity during the process of cross-linking given the rise of 
the rate of cross-link formation, preventing samples from losing their designed shape as well 
as from cell sedimentation issues. Decreasing the gelation time also provides a faster-pace 
deposition in printed scaffolds with several layers, reducing the time for each layer to achieve 
certain mechanical integrity and facilitating the generation of more complex and on a bigger 
scale constructs. Hydrogels in this project were only cultured at different H202 molar ratios, 
since HRP is found non-cytotoxic regardless of its concentration, and therefore its 
employment is considered safe for any prospective Gel/HA hydrogel obtention. 
Both 70/30 and 30/70 Gel/HA compositions showed an increment in the number of spread 
cells and general cell density, given the rise of the number of cross-links. Despite the 
impossibility of analysing the mechanical properties of any cross-linked samples for the 
same reason, we could not provide rheological data of the precursor solutions, we predicted 
an increase of the overall hydrogel stiffness as a result of the increment of cross-link density, 
which can be detected by cells and modify their behaviour.  
Antibody against myosin could not be recognised in the different culture assays (Figure 46), 
however, a change in cell morphology could be appreciated regarding the fusion of some 
cell cytoskeleton and stretched morphologies in some of the pictures when compared to the 
rest of the conditions. Possible reasons for the failure of the antibody against myosin were 
thought to be related to the use of inadequate concentrations of the MF-20b or Cy3 antibodies 
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(for 8x106 cells/mL) during the staining process or the own failure of any of the two 
antibodies. The failure of the differentiation-induced medium is unlikely to be the cause 
since cell morphological differences (more elongated shapes without lateral nanopodia and 
thicker cytoskeleton structures (more absorbance)) seen in samples should not have 
happened in the absence of ITS-X. Samples cultured in differentiation medium seemed to 
retain their original higher cell numbers, which supports the idea of no probable cell 
cytotoxicity or damage during printing. The number of spread cells, in comparison to the 
rest of 30/70 samples, was also observed to significantly increase with no apparent reason.  
Even though the staining of some conditions could not be completely achieved, all the tested 
hydrogels, regardless of their composition or culture condition, were successfully generated 
by our designed 3D printing protocol, which denoted the lack of any harmful shear stress or 
cytotoxicity during the process. We could therefore establish an advantageous alternative for 
the processing and cell encapsulation of enzymatically cross-linked Gel-Tyr/HA-Tyr 
hydrogels, becoming less time consuming and dependent on the researcher’s ability to 
manually cross-link samples.     
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Figure 45. Adhesion of cells C2C12 in Gel/HA 70/30 hydrogels at 7 days of culture 
(above) by means of 3D printing. H202 concentration in samples was increased from 2 
mM to 3mM, 4mM and 5mM. Actin and DAPI were used to stain cell cytoskeleton 
(green) and cell nuclei (blue) respectively. The increase of cell density between 
compositions may be mostly due to a general increase in the cross-linking density (bottom 








































Figure 46. Adhesion and differentiation of cells C2C12 to Gel/HA 30/70 hydrogels at 7 
days of culture by means of 3D printing (control, H202 5mM, differentiation). Antibody 
against myosin was not recognised, although differences in morphology could be 
observed in the actin cytoskeleton when compared to the other conditions (red arrows). 
Again, an increase in H202 in comparison to control samples denoted an increase in the 
cell density, most probably caused by the increase in the polymer cross-linking density 






5.  Conclusion  
Improving the ability to predict the efficacy and toxicity of drug candidates earlier in the 
drug discovery process speed up the introduction of new drugs into clinics. In drug 
discovery, the conventional procedure of screening drug compounds starts with 2D culture 
tests, followed by animal model tests and finally clinical trials. 2D and animal models are 
usually nonpredictive and often unrelated to in vivo human responses, given their different 
nature and organization of native tissues. 3D in in vitro systems, albeit still encountering 
some serious limitations, have remarkably advanced the drug screening process since 3D 
tissue models can closely mimic native tissues and, in some cases, the physiological response 
to drugs. 3D bioprinting, among the different in vitro systems, is a highly promising 
technology that possesses numerous advantages such as high precision control over size, 
high-throughput capability, tailored and accurate microarchitecture, coculture and 
vascularisation ability with minimum cross-migration of cells, and low risk of cross-
contamination (164,290). Besides, 3D bioprinted tissue models for pharmaceutical use are 
not subject to the rigorous safety and ethical issues required for implantation into humans, 
easily providing valuable relevant preclinical data. 
The present study offered a complete evaluation of the different operational parameters 
involved in the design of a viable and reproducible 3D bioprinting protocol of enzymatically 
cross-linked Gel-Tyr/HA-Tyr hydrogels as potential skeletal and chondrogenic 3D models 
for future applications in vitro drug testing and toxicology analysis of drug candidates.  
Influencing parameters such as bioinks viscosity, gelation time, nozzle geometry and 
diameter, flow rate, pneumatic pressure, polymer solution weight, shear rate, temperature, 
cell sedimentation rate, as well as standoff distance were evaluated and adjusted based on 
their use in two different printing modalities, extrusion-based for the formation of hydrogel 
droplets and droplet-based micro-valve bioprinting for the ejection of cross-linking. After a 
laborious assessment, we eventually demonstrated the excellent viability of our designed 
bioprinting protocol by means of several cell culture studies, which quantified the possible 
cell cytotoxicity and mechanical stress damage not only in different hydrogel compositions 
but also in various culture conditions. This evaluation was performed via the analysis of cell 
viability, density, morphology and behaviour at different time points, resulting in a very 
positive outcome and potential application development.  
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Both systems were found to possess advantages and disadvantages regarding bioinks 
limitations and printing dynamics. Extrusion bioprinting offered no range limitation either 
in terms of bioink’s viscosity or vehicle´s cell density, providing an extensive range of 
possibilities in multi-material printing. Yet, as it was revealed, very poorly viscous materials 
(as the bioinks meant for this project) were lacking independence from external stimuli such 
as the printing pressure or the own bioink’s weight at the cartridge reservoir, generating 
significant unstable flow rates either during the same printing process or when tried to 
replicate. Moreover, extrusion-based systems possess limited printing resolution, limiting 
sometimes the direct fabrication of some microstructures. It is reasonable to think that, for 
non-continuous printing applications like ours (droplets), extrusion bioprinting might not be 
the most beneficial strategy on the table, however, with previous extensive calibration 
hydrogel droplets with very low-resolution requirements were eventually and successfully 
replicated, without any related findings of cell sedimentation or cell damage. Nozzle 
geometry also played an important role in keeping constant flow rates, where tapered nozzles 
tips, albeit offering higher-pressure gradients at lower shear stress levels, exhibited the 
greatest sensitivity to pressure changes, difficulting the dispensing of similar droplets at high 
sample volumes. This could be sorted out by the selection of cylindrical nozzle tips, well-
known geometries for general purpose applications and more precise depositions counting 
with a vast variety of diameters and tip lengths. Given the very low viscosity bioinks 
presented in this study, we decided to opt for chamfered cylindrical tips, a particular type of 
cylindrical geometry with smaller tip contact surfaces specially designed for microdot 
applications requiring very stable flow rates and without gripping issues.    
On the other hand, droplet-based micro-valve guaranteed a more accurate dispensing due to 
the poor influence of applied pressure and the absence of nozzle tip. Another benefit relies 
on its non-contact working mode. Nozzles in this system do not need to be in direct contact 
with samples or the substrate surface in order to dispense material, becoming exempt from 
clogging issues at the tip exit and thus providing the easiest and most effective dispensing 
mechanism of these two modalities. However, droplet-based modalities are rather 
constrained by one important parameter: time. Poor viscosity and pico-scale flow rates tend 
to originate longer printing times, which enhance the effect of sedimentation at lower cell 
densities (ρ > 3x106 cells/mL). In addition, lacking a nozzle tip, albeit preventing material 
build-up at the tip itself, does not prevent material clogging inside the micro-valve, forcing 
the worker to perform regular deep cleaning practices between cross-linking steps. In 
systems with single micro-valve printheads like our case, this inconvenience can induce 
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large increments of the time required for printing in multi-step protocols, eventually 
becoming detrimental for cells as well as for samples mechanical integrity. In the current 
circumstances, droplet formation and cross-linking of all analysed hydrogels yet feasible by 
both methodologies were decided to be performed by extrusion bioprinting and micro-valve 
ejection respectively.  
Parameters affecting cell viability were evaluated regardless of the technology, focusing on 
the maximum shear stress and pressure drops achieved in laminar flow regimes (Re < 2100). 
Wall shear stress was found to be relatively low in comparison to the established threshold 
level in other studies (τmax < 5 kPa) with values from 30 Pa (η < 10 mPa·s, Q < 20 µL/s, 23G 
nozzle) to 250 Pa (η < 10 mPa·s, Q < 20 µL/s, 27G nozzle) during very small printing 
periods. Even in the event of a sudden increase of bioinks viscosity (η < 100 mPa·s) due to 
temperature variations, shear stress in extrusion-based printing should not be expected to 
reach dangerous stress levels, assuring correct cell dispensing and viability in less favourable 
situations. Pressure drop, on the other hand, presented a different possible scenario when 
reaching the application of certain levels of pneumatic pressure (P > 200 kPa) at high nozzle 
gauges, very usual in extrusion systems, as the maximum pressure applied by some current 
benchtop 3D printers on the market may be insufficient. Similar problems appear for 
minimum pressure resolutions, which in some cases have been seen to reach the 6 kPa, much 
higher than the pressure difference required to significantly alter printing flow rates in our 
system (± 1 kPa). The micro-valve system was capable of producing small accurate cross-
linking ejections at low pneumatic pressure (P < 15 kPa), being more effective for high-
resolution applications in low viscous bioinks.  
Cell viability and adhesion did not either present significant differences in cell survival when 
using extrusion bioprinting even when H202, cytotoxic on cells at relatively low 
concentrations, was increased. We can confirm then that the cross-linker deposition, by 
either one or the other method, would be accurate enough and totally safe for the cells until 
further investigation.  
CF-KRB solution used for the hydrogel precursor solutions was found acceptable for 
hydrogel cross-linking of Gel-Tyr/HA-Tyr samples, however, we strongly suggest the 
investigation of buffer solution alternatives for future research as its use during long 
hydrogel formation processes presented a significant rise in cell death of cells C2C12 and 
other used cells types in previous studies.  
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Gelation times were decreased by means of increasing any of the used catalysers HRP/H202 
during the cross-linking process, where higher H202 concentrations did not apparently 
change samples cell viability but incremented the average cell density of all compositions 
when compared to the initial H202 ratio. From our point of view, higher cross-linking 
densities seemingly generated less swollen hydrogels with lower cell to cell distances, 
artificially raising the cell population numbers. However, it is also a real possibility that 
higher cross-link ratios increase the general stiffness of hydrogels, generating more attractive 
environments for cell proliferation. This appealing mechanism, schematically described in 
Figure 46, could be employed in further printing applications to help maintain the structural 
integrity of the cell-laden hydrogels of this consistency as well as to decrease the average 
printing time of more complex hydrogel structures. About the above, it is important to 
highlight that an increase of the cross-linking density may be responsible for not only one 
but a few hydrogels physical properties such as hydrogel pore size and pore 
interconnectivity, swelling ratio, hydrogel stiffness and degradation rate, properties that are 
mainly responsible for cellular behaviour and whose alterations could also undermine some 
already achieved optimal behaviours. We hence suggest an extensive analysis of some of 
these properties prior to any further application.   
In summary, we successfully designed and implemented a 3D bioprinting protocol for 
enzymatically cross-linked Gel-Tyr/HA-Tyr hydrogels without any side effects, which was, 












Figure 47. Influence of the cross-linking HRP/H2O2 concentration on different hydrogel 
properties. Depending on the cell type, cell morphology would be positively or negatively 






6. Future work: “What’s next?” 
Bioink support strategies for complex hydrogel scaffolding 
As we have repeatedly commented in our study, soft hydrogels such as 2% w/v Gel-Tyr/HA-
Tyr generate less stable and significantly weaker 3D constructs that tend to collapse during 
the fabrication process and/or upon exposure to physiological conditions. Furthermore, the 
low mechanical strength and high wettability of hydrogel bioinks often result in poor shape 
fidelity and spreading of the deposited filaments or pico-scale droplets, making high-
resolution fabrication of complex tissue structures impractical. 
In order to overcome this limitation, numerous strategies have been developed for stabilising 
the deposited bioink in a non-destructive manner at different stages of the printing process, 
which can be divided into two main categories: bioink cross-linking and bioink support. The 
effectiveness of the bioink cross-linking strategy when used as the only means of 
stabilisation depends on, as it has already seen in our project, (1) a fast cross-linking reaction 
during or shortly after deposition in order to avoid spreading and collapsing of the printed 
material, and (2) the printing’s scheme ability to self-support bioinks deposition without 
collapsing until cross-linking of the bioink is attained. Most biologically relevant structures, 
however, contain complex spatial geometries that generally include elements with overhang 
angles, making fabrication impossible without providing adequate support to overhangs 
even at rather fast cross-linking processes.  
Printing strategies have been developed, in which the fabricated structures are supported by 
external elements, that hold and preserve their shape until final structural and mechanical 
integrity are accomplished through the cross-linking process (291,292). These elements, 
represented in Figure 48, can be printed at the same time as bioinks as part of the fabrication 
procedure. At the end of this process and once the bioink structure is stabilised, the support 
materials can be extracted or preserved as an integral part of the printed structure.  
The most simple supporting strategy is based on the fabrication of external structures 
incorporated in the digital design of the object that stabilises and hold the different deposited 
bioinks, providing them with an external and/or internal platform to lean on. These structures 
are generally composed of acellular natural or synthetic biocompatible substances with 
excellent mechanical properties and good printability. In the case of hydrogels, this can be 
translated in bioprinting using cell-laden hydrogel with another more viscous sacrificial 
hydrogel or hybrid bioprinting of biodegradable synthetic polymer shell with cell-laden 
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hydrogel bioinks. Some good examples of synthetic supporting materials are Pluronic F127 




















Pluronic F127 is a biocompatible co-polymer widely used as a sacrificial material and a  
bioink’s component alike. Above a critical micelle concentration and temperature (T > 30º 
C), the PF127 undergoes thermally reversible gelation (293), being highly printable and easy 
to extract by gradual dissolution in aqueous media or by rapid liquefaction at low 
temperature (4ºC) (294,295). Pure PF127 has been used as a sacrificial support material that 
maintains the printed structure not only from the outside but also from the inside, sometimes 
employed for the creation of hollow channels for scaffold vascularization inside the 
Figure 48. Schematic representation of printout stabilisation methods. (a) Bioink cross-
linking- The bioink is reinforced during or after the printing process using ionic, physical, 
light irradiation or enzymatic cross-linking mechanisms. (b) Bioink support – The 
incorporation of temporal or permanent elements that mechanically support the extruded 
or ejected bioink to form the final printed structure. (I) The support ink is or can be co-
printed with the bioink, stabilising it externally or internally. Afterwards, the support can 
either be left (support bioinks) as an integrated part of the structure or sacrificed (fugitive 
or sacrificial bioinks) to leave voids within. Support material can be patterned around 
(“extra-structural”) and/or within (“intra-structural”). (II) Pre-casted support – The bioink 
is deposited into a bath pre-filled with support medium of similar density that entraps and 
retains the position of the deposited strands, allowing free-formation of the printing 
structure in all dimensions. Later, after the bioink’s shape is reinforced, this support can be 






fabricated hydrogel. Polycaprolactone (PCL) on the other hand, is a common example of a 
non-sacrificial stabiliser. PCL is a biocompatible, biodegradable, flexible synthetic polymer 
with a low melting point of 60ºC. Molten material can be extruded into filaments by fused 
deposition modelling (FDM) and rapidly cooled down by low-temperature atmospheres, 
generating a rigid, water insoluble supporting framework (296,297). Depending on PCL 
fibre spacing, orientation, and/or thickness, it is also possible to tune the mechanical stiffness 
of the graph, optimising its properties to match that of the desired tissue and thus the 
microenvironment for the seeded cells (192). Furthermore, it is also possible to implement 
both classes of supporting materials, in order to provide additional support and to generate 
perfusable, complex, vasculature-like structures.   
Unlike natural polymers, some synthetic polymers have the risk of low biocompatibility as 
well as toxic degradation by-products (298). Using natural polymer-based hydrogels both as 
cell-laden and supportive sacrificial bioinks works as a tool to mimic the ideal ECM 
microenvironment for the cells. Alginate and agarose are highly used polysaccharide-based 
natural polymers as material support, derived from brown algae and seaweed respectively. 
Alginate has similar properties to the natural ECM, controllable viscosity, highly printable 
due to its inherent shear-thinning properties, being mostly cross-linked with CaCl2 
(especially at room temperature) (299). Agarose has a rapid and gradual gelation kinetics 
ranging from 20ºC to 70ºC, suitable for mould-based fabrication in 3D bioprinting.  
A few important challenges remain when using these support materials though. Sacrificial 
bioinks should allow oxygen and nutrient diffusion through the printed structure as well as 
possess a controlled degradation rate, which is not the case with very dense structures such 
as agarose strips or cross-linked alginate. Besides, cross-linked alginate that requires the use 
of sodium citrate or ethylenediaminetetraacetate (EDTA) treatments for its dissolution, 
hinders calcium-dependent cell attachment. Other support materials need to be heated to 
high temperatures as agarose or cooled down as PF127 to become printable, getting away 
from cell physiological temperature. Moreover, while the PF127 is highly printable, it has a 
low cytocompatibility when used at high concentrations. Similar situations are encountered 
with alginate and agarose when used alone, which may induce apoptosis due to the poor cell-
binding domains necessary for cell adhesion and proliferation and hence they are usually 




Commonly, collagen, gelatin,  hyaluronic acid, dextran and fibrin, are employed to develop 
natural polymer-based bioinks (300) in the company of poor adhesive but highly printable 
materials (alginate, agarose, etc.), enhancing scaffolds integrity during and after being 
printed and washing out afterwards the non-crosslinked components (301).  
Recently, the development of new sacrificial bioinks has opened new possibilities for 
hydrogel bioprinting. Some of these bioinks like 3.5% Agarose: 10.5% Alginate (302), 9% 
Methylcellulose: 5% Gelatin (303,304), or 9% Methylcellulose: 3% Alginate (305) can take 
place at room temperature and self-erode in the cell culture medium at 37º C without leaving 
no residues behind. The hydroxyl groups present in alginate and agarose lead to the 
formation of hydrogen bonds between these two polymers, whilst the calcium ions present 
in the cell culture medium lead to very loose cross-links between alginate chains. The use of 
any cross-linking agents has important advantages like ease of implementation, reproducible 
results at every batch, and a higher speed of printing (302).  
The addition of inverse thermal gelling polymers (gel T > 37ºC) such as methylcellulose 
(MC), a water soluble derivative of cellulose forming viscous solutions in water, can be 
applied as an agent to temporary increase the low viscosity of other polymer solutions when 
used at low density, like alginate or gelatin. Since MC does not contribute to the gelation, it 
is therefore released from the scaffold after the possible cross-linking of the rest of the 
polymer components, returning the cross-linked hydrogel to its original characteristics as a 











Figure 49. Conceptual liver organoid design by 3D bioprinting. Left, printout sacrificial 
support material (8% Alginate: 3% Gel) (phenol red added for better visualisation) for 
vascularization of the portal and central veins. 2% w/v 30/70 Gel-Tyr/HA-Tyr hydrogel 






Given the good biocompatibility and printability of Gel-Tyr/HA-Tyr hydrogels, the 
implementation of support/sacrificial materials in the printing process could be 
advantageous for the development of potential models for skeletal muscle, chondrogenic or 
hepatic tissue (33-35,289). As we can observe in Figure 49, physically cross-linked 
Alginate-Gel bioinks can be used as fugitive materials for support and vascularisation until 
enzymatic cross-linking of Gel/HA hydrogels is complete. Afterwards, due to the solubility 
of alginate and gelatin at culture medium temperature (37ºC), all non-crosslinked materials 
would be washed out, only remaining the hydrogel scaffold. Same could be devised for 
internal support using gelatin, HA or methylcellulose as temporary tickening agents during 
printing to improve bioinks poor viscosity  
Hybrid bioprinting and multiphasic hydrogels (Figure 50 and 51) can also benefit from 
bioink support materials in Gel/HA hydrogels. One common orthopaedic issue to be 
addressed by bioprinting strategies is an osteochondral (OC) defect affecting simultaneously 
bone- and cartilage-associated zonal compartments in human joints. Cartilage ECM is 
mainly formed by fibres of collagen type II of different orientations as well as characterized 
by layers of different biochemical composition and cell density. This cartilage layer is 
connected to a calcified cartilage layer and the underlying subchondral bone region. Most of 
the tissue engineering and regenerative medicine techniques applied to the repair and 
regeneration of cartilage have not addressed the simultaneous repair and regeneration of the 
subchondral bone, something suggested by recent research studies to be the most common 











Figure 50. Development of osteochondral scaffolds from monophasic to multi-phasic to 
mimic the natural OC environment and provide biological and biomechanical cues to the 





The development of biphasic hydrogel scaffolds combined with hybrid bioprinting could be 
used for the generation of multi-layered full-thickness osteochondral tissue substitutes, with 
individual geometry based on clinical imaging data, and extrusion-based 3D printing of a 
cell-laden bioink with primary chondrocytes and a mineralised biomaterial phase. Such 
scaffold could be used for early treatment of cartilage and osteochondral defects at an early 






















Figure 51. Tissue substitutes for multi-layered osteochondral (OC) defects via extrusion 
or 3D plotting. (a) Multi-layered OC tissue defects require different repair strategies 
depending on the layer’s architecture, composition, and cell type. (b) A combination of 
cell-laden hydrogel (AlgMC) and partly mineralised CPC (calcium phosphate cement)-
supported zones resembling articular cartilage (ii), underlying layers of calcified cartilage 
(iii) and subchondral bone (iv). (c) Investigation process regarding mono/biphasic scaffold 
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